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Summary
Transitions between cellular states are involved in all kind of biological events: cells dif-
ferentiate during development, assume different phenotypes because of experimental or
pathological conditions, and change their identity during cellular reprogramming. The possibil-
ity to induce specific cellular transitions represents a great opportunity for disease treatment
and regenerative medicine. Cellular states are maintained by gene regulatory networks,
and the manipulation of their master regulators can trigger cellular transitions. Modulating
signal transduction is a convenient way to obtain such transitions avoiding transfer of genetic
material, with substantial benefit in terms of clinical safety. While multiple methods separately
consider gene regulatory networks for cellular transitions, and the role of signalling pathways
in biological processes, no approach so far integrates the two regulatory layers in order to
identify signalling perturbations that can induce desired cellular transitions.
This thesis presents methods for the prediction of signalling molecules or pathways that
regulate the gene regulatory network (GRN) of a given cellular state and induce its transition
to the desired state. The overall approach consists in the integration of signalling pathways
and GRNs to model how signalling cues act on the transcription factors (TFs) that sit at
the interface between the two regulatory layers, and cause changes in the gene expression
program. To this end, gene expression data was used to estimate the probability of signalling
molecules to activate and inhibit interface TFs, combined with in silico perturbations of the
Boolean GRN underlying the desired cellular conversion.
This approach was systematically applied to the prediction of signalling molecules and
pathways involved in cellular transitions, with particular focus on reprogramming and differen-
tiation cases. The predictions obtained consistently recapitulated experimental perturbations
and literature knowledge. Additionally, the methods proposed outperformed available tools
for the prediction of both signalling molecules and pathways.
To show the applicability of this approach to disease treatment in an animal model,
signalling perturbations were predicted for the reversal of cirrhotic liver state to healthy in rat.
1
LIST OF TABLES
Experimental results confirmed that the activation of the angiopoietins receptor Tie2 produced
favorable changes in the gene expression of TFs that play an important role in cirrhosis.
Finally, this approach was applied to the analysis of limb regeneration upon amputation in the
salamander Ambystoma mexicanum. Using time series gene expression data, predictions
were generated to retrieve the signals activated and inhibited along the regeneration process.
Literature evidence connected predicted pathways and proteins to specific regeneration
stages, clarifying their relation to wound healing, blastema formation and differentiation.
2
1 Introduction
The Greek philosopher Heraclitus has been quoted as saying “change is the only constant
in life”. At the cellular level, this is certainly true: transitions between different states during
development bring the embryo to form a complete organism, with specialized cells, tissues and
organs. Changes in cellular state are also required to adapt to new conditions and response
to external stimuli, and are detrimental when associated with pathologic conditions. The
ability of inducing specific cellular transitions is a fundamental tool for disease treatment and
regenerative medicine. Cellular states are modelled as gene expression profiles determined
by gene regulatory networks. These models have been used for the selection of transcriptional
cellular determinants before, but their manipulation raises safety concerns for therapeutic use.
On the other hand, chemical compounds, small molecules and growth factors can trigger
cellular transitions by acting on the signalling network. Signalling has so far been studied in
isolation from the gene regulatory network that determines a cell’s state, but their integration
needs to be achieved in order to computationally select signalling perturbations that can
induce desired cellular transitions.
In this chapter, cellular transitions are described and their relevance is delineated in Sec-
tion 1.1. The use of gene regulatory networks as models for cellular states will be introduced
(Section 1.2). The role of signalling in relation to cellular state, and the computational tools
available for its analysis are presented in Section 1.3. Finally, an introduction is given for the
animal models used in this thesis, which are used to get insight into disease and regeneration
(Section 1.4).
1.1 Cellular transitions for disease treatment and regenerative
medicine
A cellular transition, also referred to as cellular conversion, is here defined as the shift of a
cell from an initial state, to a desired cellular state. Depending on the nature of the difference
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between the initial and final state, the transitions can be classified into two broad categories:
cell state transitions and cell fate transitions.
Cell fate transitions concern changes in cellular identity, including differentiation, trans-
differentiation and reprogramming. Following the seminal work of (Takahashi and Yamanaka
2006), the induction of cell fate transitions has found many applications in multiple areas
of biomedical research. On one hand, the possibility of deriving cells that are difficult to
obtain from patients in the lab has revolutionized the field of disease modelling by overcoming
the limitations associated with animal disease models, allowing the study of monogenic,
chromosomal and complex disorders (Avior, Sagi, and Benvenisty 2016). Examples of cell
types obtained in vitro for disease modelling are neurons (Chang et al. 2018; Hong Li et al.
2018), cardiomyocytes (Branda˜o et al. 2017) and hepatocyte-like cells (Parafati et al. 2018).
On the other hand, the induction of cell fate transitions has a potential application in
regenerative medicine, which has the objective of restoring the functionality of tissues or
organs by the replacement of damaged cells with induced cells, present in situ or transplanted.
Extensive effort has been put towards in vivo reprogramming to obtain hepatocytes (Song
et al. 2016), β-cells (Q. Zhou et al. 2008), cardiomyocytes (Qian et al. 2012), and others, as
reviewed in (Srivastava and DeWitt 2016). The transplantation of cells and tissues obtained
in vitro is already used in therapy, for example for the treatment of epidermolysis bullosa
(Hirsch et al. 2017), or ADA-SCID, a rare immunodeficiency syndrome (Kuo and Kohn 2016).
In both disease modelling and regenerative medicine, the experimental challenge is
to induce cells to change their identity in a controlled manner. This can be obtained by
inducing a pluripotent state first and then deriving more differentiated cells from it, as in the
case of induced pluripotent stem cells (iPSCs) stimulation and differentiation, or by direct
transdifferentiation of the initial cells to the desired type (J. Xu, Du, and Deng 2015).
Cell state transitions can be defined as the phenotypic conversion within a same cell
type, such as transitions between healthy and disease states, between treatment with small
molecules or growth factors and control state, or between different cell culture conditions.
The interest in inducing these transitions is manifold. The insurgence of a disease can
4
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be considered at the cellular level as a cell state transition, as cellular identity might be
unaffected, but gene expression, signalling activity, metabolic state, and function can be
compromised. In this sense, a successful cure is one that induces the transition between
the disease and healthy cellular state. In other cases, cellular transitions are a consequence
of experiments performed to clarify the effect of perturbations on the cellular state. For
instance, the development of therapeutic drugs can be extremely expensive, so the initial
assessment of a compound activity and toxicity is often relying on cell-based assays, which
compare the initial and the treated cellular state to assess the effects of chemical compounds
(Michelini et al. 2010; O’Brien et al. 2006). Similarly, cellular transitions are also induced
when performing experiments in order to understand drugs mechanism of action, and in
general to study the mechanism of cellular biological processes. The discovery of new drugs
for a disease or the proteins involved in a particular phenotype can therefore be reframed as
the identification of factors that can trigger a desired cellular conversion.
Overall, the induction of desired cellular transitions is of clinical interest, as it allows to
revert diseased cells to normal counterparts, or to derive desired cells and organs for cell
replacement therapies. Computational methods can be instrumental to the application of
cellular transitions in therapy by reducing the cost and time required for the experimental
discovery of the factors that are able to trigger the desired transition.
1.2 Gene regulatory network models for cellular transitions
Conrad Waddington introduced in 1957 the intuitive representation of cellular differentiation
as a ball moving in an “epigenetic landscape”, an inclined and rugged surface with multiple
valleys and stable points (Waddington 1957). Stem and progenitor cells descend following
valleys towards a more differentiated cell type, and on the way encounter forking points,
which represent metastable cellular states that are forced to adopt one of few possible
states by undergoing transcriptional changes. The topography of the “epigenetic landscape”
is thus defined by the coordinated expression of genes emerging from the interaction of
transcriptional regulators, termed gene regulatory network.
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1.2.1 Gene regulatory networks as underlying programs defining cellular
states
The differences in gene expression observed between two cellular states might span thou-
sands of genes, but each gene expression program (and thus the cell state) is maintained
by a gene regulatory network (GRN) containing only several genes. GRNs are used as
models that represent the transcriptional interactions occurring among genes in a particular
cellular state. While the potential interactions between transcriptional regulators and their
gene targets are encoded in the genomic sequence, the interactions taking place in any
specific cellular condition are determined by the expression of the regulators (S. Huang 2012)
(Figure 1.1).
Figure 1.1: The interactions between transcriptional regulators are defined from the genomic sequence,
as is the DNA sequence that defines if a transcriptional regulator can bind the regulatory region and
modulate the expression of other genes. However in different cellular conditions, each regulator can
be expressed or not because of external factors, resulting in different portions of the overall GRN
being active. Figure from (S. Huang 2012).
There are multiple modelling formalisms used to represent gene regulatory networks.
Boolean modelling was first introduced by Kauffman in the 1970s and is one of the most
6
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widely used approaches. Transcriptional regulators activity was shown to follow a sigmoid or
“switch” function, which can be approximated with a step function resulting in two discrete
states (H.-C. Chen et al. 2004). Consistently with this observation, in the Boolean framework
genes can take one of two states (active or inactive), and their state is defined through logic
functions by the state of their regulators (Glass and Stuart A. Kauffman 1973; S. Kauffman
1969). Gene expression profiles can be reduced to vectors of Boolean gene states, which
are used to represent cellular states. Among all possible Boolean states there are some that
are stable, meaning that if no perturbation intervenes on the GRN, the states of each gene
remain constant with updates of the network state. These stable states in the network state
space are called attractors. Kauffman suggested that each stable cellular state or cell type
can be associated with an attractor (Stuart A Kauffman 1993), so that cellular transitions
correspond to shifts between network attractors (S. Huang 1999). Boolean modelling allows
to capture coarse-grained properties of large GRNs, while also simplifying the construction of
models from gene expression data (S. Huang 1999). For example, the Boolean modelling
formalism allows to represent experimentally observed phenotypes and predict the outcome
of novel perturbations. The manual reconstruction of Boolean models connecting signalling
and transcriptional regulators allowed to clarify the role of specific proteins in the context
of Th cell differentiation (Naldi et al. 2010), terminal differentiation of B cells (Me´ndez and
Mendoza 2016), and mesoderm specification in Drosophila (Mbodj et al. 2016). Boolean
GRN models recovered known phenotypes during the differentiation of myeloid progenitors
(Krumsiek et al. 2011) and correctly predicted the outcome of perturbations applied to mouse
embryonic stem cells (H. Xu et al. 2014) and to the hematopoietic system (Moignard et al.
2015).
1.2.2 GRN models for cellular transitions
The conversion of fibroblasts to myoblasts by over-expression of the transcription factor (TF)
Myod (Davis, Weintraub, and A B Lassar 1987), and the induction of pluripotent stem cells
from fibroblasts with the activation of only four TFs (Takahashi and Yamanaka 2006), opened
the way to the manipulation of TF expression for the purpose of inducing cellular conversions,
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which has become the most widely used strategy for lineage reprogramming and generation
of pluripotent cells. A number of computational methods exists for identifying the TFs that can
trigger cellular reprogramming or differentiation using gene expression data. Given a GRN, it
is possible to identify its master regulators and shortlist TFs that can trigger changes in the
GRN state, resulting in cellular transitions. Multiple features are used in order to identify such
master regulators (Hartmann, Ravichandran, and Sol 2019), among which:
• Gene expression of the TFs in the GRN
• Network topology and network motifs, such as positive circuits and strongly connected
components, which play an important role in shaping the GRN attractor space
• GRN attractor states that can be reached with in silico perturbations of GRN components
and their combinations
Effective computational methods usually combine these features for the prediction of TFs
triggering cellular transitions. For example, in SeesawPred the normalized ratio difference
(Okawa et al. 2016) used to prioritize TFs that show significant change in daughter cells
compared to progenitors is combined with the identification of strongly connected components
(Hartmann, Okawa, et al. 2018, see Appendix). CellNet compares the gene expression of a
query dataset to the reference expression of genes in cell/tissue specific GRNs, and indicates
which genes would bring the query closer to the reference by topological measures (Cahan
et al. 2014). Mogrify selects TFs that are differentially expressed and jointly regulate all other
differentially expressed genes, therefore taking into account the topology of the GRN in its
prediction (Rackham et al. 2016). In (Lang et al. 2014), the authors use an attractor-based
landscape model to calculate the “predictivity” of TFs for a given cellular state, which is then
combined with their expression. Additionally, other computational methods exist that do not
consider GRNs but identify transcription factors that are uniquely expressed in the desired
cell type, which are to be activated in order to induce the corresponding cellular transition
(D’Alessio et al. 2015).
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1.2.3 Induction of cellular transitions with chemical compounds
The expression of master regulators is normally manipulated with the introduction in the cells
of exogenous DNA coding for the TF protein required. Multiple vectors and strategies exist
in order to obtain efficient and reliable expression of the desired proteins. Despite these
efforts, in general these approaches raise clinical safety concerns related to the integration
of exogenous DNA in the cellular genome, which can lead to insertional mutagenesis and
tumour formation (Ben-David and Benvenisty 2011; Okita, Ichisaka, and Yamanaka 2007).
Alternative DNA delivery systems that do not require integration, using both viral and non-viral
vehicles, have recently been developed (Hardee et al. 2017; Makhija et al. 2018; Uludag,
Ubeda, and Ansari 2019). However, these techniques still show very limited efficiency and
are therefore unsuitable for clinical application (Haridhasapavalan et al. 2019).
Small molecules and chemical compounds are routinely used to alter the cells environ-
ment, in order to reproduce in vitro pathological conditions, or study the cellular response to
drugs and other stimuli. In recent years, their use for cell reprogramming and differentiation
has emerged as a promising strategy for in vitro and in vivo applications (Federation, Bradner,
and Meissner 2014; Heng Li and Homer 2010; Qin, Zhao, and Fu 2017) because they provide
a valid strategy for cost-effective, transient, controllable induction of cellular transitions (De
et al. 2017; J. Xu, Du, and Deng 2015; Pesaresi, Sebastian-Perez, and Cosma 2019). Thus,
the use of chemical compounds is preferable for the generation of cells in clinical applications
(Takeda et al. 2018) (Figure 1.2).
The combinations of compounds, small molecules and growth factors that trigger cellular
transitions are defined through phenotype- and target-based screenings. Phenotype-based
screenings consist in performing multiple assays in order to identify molecules that can
induce the desired phenotype, without requiring a priori knowledge of the cellular transition
considered. On the other hand, target-based screenings use such information to restrict the
analysis to regulators of pathways involved in the cellular transition (De et al. 2017). Thus, the
identification of chemical factors and small molecules inducing cellular transitions is usually
lengthy, expensive and labour intensive (Cao et al. 2016; Y. Tang and Cheng 2017). The
9
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Figure 1.2: Schematic depiction of the derivation of cells of interest from patient fibroblasts by
either transdifferentiation or reprogramming to induced pluripotent stem cells (iPSCs) followed by
differentiation. The limitations observed in the use of iPSCs and corresponding advantages of
transdifferentiation are mentioned. Figure from (Takeda et al. 2018).
development of computational methods for the prediction of non-transcriptional perturbations
that induce cellular transitions is therefore desirable.
1.3 Signalling network models
Small molecules and chemical compounds induce cell fate transitions mainly by acting either
on signalling pathways, on the cellular metabolism, or by altering the status of the chromatin,
therefore modifying the gene expression program of the cells. Signalling events play a
major role in cellular transitions. During development, the concerted action of combinations
of signalling pathways over time dictates the formation of tissues and organs (Basson
2012; Perrimon, Pitsouli, and Shilo 2012). Multiple signalling pathways are also involved
in maintaining tissue homeostasis (Biteau, Hochmuth, and Jasper 2011). In pathological
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conditions, the deregulation of signalling pathways induces inflammation, immune response,
and disease specific phenotypes.
The signalling network consists of proteins and small molecules that can interact activating
and inhibiting each other, resulting in the transmission of external cues to the nucleus, where
the signals are integrated and the cellular response is defined. While signal transduction
is a probabilistic process that has low probability of emerging over a background of unspe-
cific protein-protein interactions, multiple strategies are used to ensure robust and correct
transmission of signals, such as compartmentalization, multimerisation, and integration of
multiple signals (Ladbury and Arold 2012). Among all signal transduction paths, there are
some stereotypical ones that have been well described and act as functional units, that were
termed canonical signalling pathways. The concept of canonical signalling has with time been
put in discussion, as more and more evidence is found that alternative signal transduction
paths exist and play important roles in many cellular contexts (Meyerovich et al. 2016; Ohta
et al. 2016; Regan et al. 2017; Voloshanenko et al. 2018). However, canonical pathways
still represent functional entities useful for the interpretation of high-throughput experiments
such as gene expression analysis, proteomics or phosphoproteomics data, where significant
differences between two conditions might be present for thousands of genes or proteins,
and pathway enrichment analysis methods are applied to identify which are the biological
functions associated with them.
Despite their central role in the regulation of all kinds of biological processes, the dynam-
ics of signalling events remain difficult to study experimentally because signalling pathways
involve many different types of interactions among proteins (M. J. Lee and Yaffe 2016):
phosphorylation and other post-transcriptional modifications, complex formation, compart-
mentalization, transport. Phosphorylation is the main strategy used for signal transduction in
many canonical pathways (Ardito et al. 2017) and results primarily in transcriptional regulation
(Needham et al. 2019). Phosphorylation can happen on different amino acids of a protein
(phosphosites) controlling the activity state of the protein by inducing changes in protein 3D
structure, cellular surface charge, binding to protein partners (M. J. Lee and Yaffe 2016).
However, current phosphoproteomics techniques do not allow an absolute, proteome-wide
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quantification of phosphorylation events (Needham et al. 2019). In fact, in any given phos-
phoproteomics experiment only 40 to 60% of the phosphosites existing across the proteome
are captured (Invergo and Beltrao 2018; Vlastaridis et al. 2017). Additionally, only 3% of all
human identified phosphosites have known functional role (Needham et al. 2019).
Given the limitations and the constraints that characterize phosphoproteomics experi-
ments, many studies have used gene expression data to get insights into signalling events.
The numerous attempts to assess the level of agreement between transcriptomics, proteomics
and phosphoproteomics data reached discordant conclusions, with some studies finding
moderate correlation, while others only reported qualitative similarities among the measure-
ments (Gnad, Wallin, et al. 2016; Kandasamy et al. 2016; Olsen et al. 2010; Pines et al.
2011; Richter et al. 2015; Rotival et al. 2015; Blevins et al. 2019). Overall, transcription rates,
protein abundance and phosphorylation of protein residues cannot generally be considered
equivalent or informative of each other. On the other hand, cellular response to signalling
perturbations has been shown to change across cellular populations according to their state,
and in particular to the abundance of specific signalling proteins, prior to perturbation (Niepel
et al. 2017; Strasen et al. 2018).
1.3.1 Use of gene expression in signalling analysis
Multiple computational approaches exist that aim at explaining how the transition between
two gene expression profiles is associated with signalling events: either in the context of drug
profiling, where the methods are used to predict drugs mechanism of action, or in diseases, an
approach particularly useful to identify dysregulated signalling pathways in cancer. Two broad
classes of computational methods exist, namely GRN-free and GRN-based approaches.
GRN-free methods map gene expression data on signalling pathways in order to define
whether they are activated or inhibited, and focus mostly on differentially expressed genes
(DEGs). GRN-based methods, on the other hand, consider also transcriptional regulation
interactions in their analysis and in particular try to explain expression changes in groups of
genes with their upstream signalling regulators.
Starting with Connectivity Map (Lamb et al. 2006), a number of methods for the identifica-
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tion of cellular perturbations have been developed. These methods (Lamb 2007; Parikh et al.
2010; Schubert et al. 2018) compare the signature of a query perturbation with a database
of gene expression signatures, obtained perturbing the signalling network in a controlled
manner (with drugs and chemical compounds, signalling pathways inhibitors and activators,
overexpression or knock-down of signalling proteins), and select candidate perturbations
based on the similarity of signatures. Their predictions are limited to the perturbations present
in their corresponding databases and rely on signatures from a limited set of cell types or
lines.
Another class of GRN-free methods is represented by pathway enrichment approaches
that use transcriptomics data to infer which signalling pathways are associated with different
cellular conditions. They comprise methods based on over-representation of DEGs in
signalling pathways (Sartor, Leikauf, and Medvedovic 2009; Subramanian, Tamayo, et al.
2005), and approaches taking into account pathway topology or cross-talk (Dutta, Wallqvist,
and Reifman 2012; Massa, Chiogna, and Romualdi 2010; Naderi Yeganeh and Mostafavi
2017; Tarca et al. 2009). Such methods have been successfully applied to the understanding
of multiple diseases, with a particular focus on cancer (Dutta, Wallqvist, and Reifman 2012;
Sebastian-Leon et al. 2014). Additionally, they were used to study differentiation trajectories
and reconstruct the role of signalling pathways during development (Dutkowski and Ideker
2011). Because canonical pathways are highly variable depending on the database used
(Kirouac et al. 2012; Tu¨rei, Korcsma´ros, and Saez-Rodriguez 2016) and subject to extensive
crosstalk (Schaefer et al. 2009), a different class of methods tries to address this problem by
predicting sets of proteins corresponding to functional units, termed sub-pathways (Amadoz
et al. 2015; Han et al. 2015; Haynes et al. 2013; Hidalgo et al. 2017; Martini et al. 2013). It is
important to notice that pathways are not predictive of the transcriptional state of their targets
(Housden and Perrimon 2014), therefore these methods give limited insight on the effects of
signalling events on the GRN.
Efforts towards the integration of the GRN in the modelling framework have been limited to
far. Various studies have presented manually-curated integrated models for individual systems.
For example in (Peng et al. 2010) the signalling activity of IKK proteins on NF-κB is captured
13
CHAPTER 1. INTRODUCTION
using both transcriptional activity and signalling activity predictions resulting from manually
curated models. (Zan˜udo and Albert 2015) presents a method to identify reprogramming
factors in manually curated Boolean models containing both signalling and transcriptional
interactions. In (Mbodj et al. 2016) a Drosophila development model built manually is iteratively
refined to match literature knowledge and experimental data. Finally, Yachie-Kinoshita et al.
2018 generated a manually curated Boolean network model for pluripotent stem cells where
pathways are represented as single nodes that can act on effector TFs and regulate the GRN.
Available general GRN-based methods use ordinary differential equations (ODEs) to model
the expression level of each gene as a function of the expression of its regulators. Signalling
molecules that are involved in the perturbation response are selected based on the fact that
their expression alone cannot explain the expression of the genes they regulate (Balwierz
et al. 2014; Cotton et al. 2015; Noh, Shoemaker, and Gunawan 2018; Osmanbeyoglu et al.
2014). These approaches need to extract parameters from a large amount of expression
data experiments, i.e. the same cell type treated with multiple compounds or other type of
perturbations. This limits their applicability to only a few well studied cell types.
Gene expression data is also used routinely to discover drugs mechanism of action (MoA),
identifying their targets and downstream effectors. There are different modelling approaches
used for this purpose, and these methods might make use of signalling networks, or be
network-free. DeMAND (Woo et al. 2015) is considered the state of the art method for the
identification of signalling proteins that are involved in the gene expression response to drug
treatment. It considers both signalling and transcriptional networks, in the form of regulons.
Regulons are in this case bipartite networks where each protein is connected to the genes
that it regulates at the level of transcription, signalling or complex formation. A signalling
protein is predicted as drug MoA if the expression of the genes that it regulates is significantly
perturbed by the drug treatment. Methods for the inference of causal signalling networks
that can explain how signalling events result in gene expression changes follow a similar
strategy. In particular, methods have been developed to reconstruct the path followed by
signal transduction from the site of perturbation to transcription factors in order to identify
drug mode of action (Melas et al. 2015) or signalling rewiring caused by genetic mutations
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in cancer (Y.-A. Kim, Wuchty, and Przytycka 2011; Paull et al. 2013). The output of these
methods are signalling sub-networks that connect the perturbation site to the genes showing
de-regulated expression. While these methods reconstruct signalling networks that are
specific for the perturbation applied, being it a ligand or a drug, they only consider superficially
how signalling triggers changes in gene expression, because they do not consider the gene
expression changes obtained indirectly through the interplay of TFs in the GRN.
1.4 Application to animal models of disease and regeneration
1.4.1 Liver cirrhosis
Liver cirrhosis is the fourth most common cause of death in central Europe and causes
more than one million deaths per year worldwide (Tsochatzis, Bosch, and Burroughs 2014).
It is defined as an advanced stage of liver fibrosis caused by chronic inflammatory injury
of the liver tissues, which might be caused by hepatitis B or C, alcohol abuse or non-
alcoholic liver diseases (Schuppan and Afdhal 2008). Inflammation induces portal and
perivascular fibroblasts and quiescent stellate cells (HSCs) to transdifferentiate and activate
into myofibroblasts. These cells are normally associated with wound healing: they deposit
collagen to strengthen the extracellular matrix and contract the edges of the wound. Generally
when the injury subsides, myofibroblasts undergo apoptosis and the fibrosis is resolved (Scott
L Friedman 2008; Hinz et al. 2007). This does not occur in chronic inflammation conditions
and myofibroblasts continue to proliferate, synthetize excess collagen, and limit the activity
of interstitial metalloproteinases (MMPs) that could degrade the type I collagen prevalent in
fibrotic liver (Scott L Friedman 2008; Schuppan and Afdhal 2008) (Figure 1.3).
In cirrhosis, hepatic angiogenesis is closely associated with the fibrotic process. The liver
wound healing process is characterized by the expression of proteins and growth factors that
have pro-fibrotic and pro-angiogenetic role such as PDGF, VEGF, FGF and TGF-β1, and
proteins involved in the remodelling of the extra-cellular matrix (ECM), such as β-catenin,
ephrins, integrins and other adhesion molecules (Ferna´ndez et al. 2009). Deregulated
angiogenesis causes the distortion of hepatic vasculature resulting in increased hepatic
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Figure 1.3: Figure from (Schuppan and Afdhal 2008) showing how chronic inflammation causes
accumulation of myofibroblasts, which produce excessive amounts of collagen and inhibit metallopro-
teinases (MMPs) resulting in liver fibrosis.
vascular resistance and portal hypertension, with consequent failure of the hepatic functions.
The hypoxic conditions induced by portal fibrosis further induce neo-angiogenesis through
the activation of hypoxia-inducible factors (Elpek 2015).
The recommended treatment of cirrhosis depends on its clinical stage, but current thera-
pies aim at avoiding the progression of the disease to advanced stages, when liver transplant
is the only available treatment (Tsochatzis, Bosch, and Burroughs 2014). Some therapeutic
strategies have been tested in order to control new blood vessel formation and promote
the regression of portal hypertension (Ferna´ndez et al. 2009). Additionally, sorafenib and
sunitinib proved effective anti-angiogenic factors in experimental models, also showing anti-
fibrotic effects (Mejias et al. 2009; Tugues et al. 2007). Thus, therapies acting against both
angiogenesis and fibrosis should be considered. Inhibition of VEGF activity however has
been associated previously with negative effects (H. X. Chen and Cleck 2009), and new
therapeutic strategies are needed. Classically, rats have been used as animal model for
cirrhosis, as their response to fibrotic stimuli is more robust as compared to wild-type mice
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(Bissell 2011). Carbon tetrachloride (CCl4) is a hepatic toxin widely used to induce liver
injury. Upon repeated insult, the rat liver develops progressive fibrosis and finally cirrhosis
(Y. Liu et al. 2013), showing great similarity with human liver cirrhosis. Additionally, the fibrotic
process is reversed upon withdrawal of the toxin, allowing to study fibrosis reversibility (Y. Liu
et al. 2013).
1.4.2 Axolotl limb regeneration
Regeneration is defined as the reactivation of developmental processes outside the devel-
opment stages in order to restore missing tissues or organs. Humans have very limited
regenerative capabilities, and liver is the only organ showing large scale regeneration, albeit
compensatory: the cells present in the liver proliferate to compensate the missing liver lobes,
but they maintain their differentiated state (Abu Rmilah et al. 2019). True regeneration occurs
in humans only at the distal portion of the digits (DOUGLAS 1972). Conversely, some animals
have higher regeneration potential and undergo epimorphic regeneration: the differentiated
structures present at the injury site de-differentiate, giving rise to a structure called blastema,
and differentiate again in the completely re-established body part. Examples of animals with
regenerative capabilities include planarians (Reddien and Alvarado 2004), zebrafish (Gem-
berling et al. 2013), echinoderms (Ben Khadra et al. 2017), and amphibians. In particular,
urodeles (newts and salamanders) show regeneration of limbs (Stocum 2017) and other
parts of their bodies, such as spinal cord (Chernoff et al. 2003), skin (Yokoyama et al. 2018),
retina (Mitashov 1996), and heart (Garcia-Gonzalez and Morrison 2014).
The neotenic salamander Ambystoma mexicanum is a classical model of regeneration
that can regrow limbs, tail, heart, liver, among others (Stocum and Cameron 2011). The limb
regeneration process upon amputation consists of 3 main phases: wound healing, blastema
formation, and limb re-development (Figure 1.4). These phases are common to all vertebrate
appendage regeneration (Miller, Johnson, and Whited 2019), and require multiple cellular
transitions.
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1 2 6543
Figure 1.4: A) Following amputation the wound epithelium seals the wound site (1), followed by
blastema formation (2) and proliferation (3). Blastema cells differentiate (4), tissues are patterned and
continue to grow (5) until a perfect copy of the original limb is obtained (6). B) Cell type composition
of the regenerating stump in the initial phases of the regeneration (inset corresponding to the area
selected in A). Adapted from (C. McCusker, Bryant, and David M. Gardiner 2015).
Wound healing The initial healing phase is common to every kind of injury, and is shared
by other animals too. It consists in the formation of the wound epithelium, which covers
the affected area within hours from the injury, and derives from keratinocytes (C. McCusker,
Bryant, and David M. Gardiner 2015; Stocum and Cameron 2011). This epithelium is
histologically different from mature epidermis. It lacks of a collagen basal lamina, and can
thus interact with other cells present in the stump. During this initial phase, migration of
fibroblasts to the wound site can be observed, alongside their active proliferation (Endo,
Bryant, and David M. Gardiner 2004). The initial proliferative response, observed also in
myotubes and neural stem cells, has been associated with the release of MARCKS-like
protein by the wound epithelium (Sugiura et al. 2016).
Blastema establishment When nerves are present at the injury site, the wound epithelium
thickens and its interaction with the mesenchymal cells is impeded, interfering with scar-
free healing and pushing the process towards regeneration (Makanae, Hirata, et al. 2013).
This regeneration-specific structure is called apical epithelium cap (AEC) and is a structure
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essential for regeneration (Thornton 1957). The signalling molecules used by nerves and
AEC are still to be completely characterized, but their interplay stimulates fibroblasts migration
to the injury site and dedifferentiation in blastema cells, which then proliferate and accumulate
in situ, while keratinocytes become non-proliferative and then dedifferentiate (C. McCusker,
Bryant, and David M. Gardiner 2015). Fibroblast growth factors (FGF) signalling has been
proven to regulate fibroblasts dedifferentiation (Makanae, Hirata, et al. 2013), while Msx1
seems to be involved in myotube-to-myoblast conversion (Antos and Tanaka 2010), but many
other factors are potentially involved. For example, both the absence of nerves and the
inhibition of macrophage signalling can impede regeneration (C. McCusker, Bryant, and
David M. Gardiner 2015).
It was shown that dermal fibroblasts, cartilage and bone, Schwann cells, and muscle cells
all contribute to blastema and regeneration. The blastema itself is thus a heterogeneous ag-
gregation of proliferating dedifferentiated cells from these tissues, together with mesenchymal
stem cells (Kragl and Tanaka 2009). Cells from different progenitors are localized in different
subregions in the blastema, and have different differentiating potential (Kragl and Tanaka
2009; Eugen Nacu et al. 2013).
Limb re-development Once the blastema is established, a new limb with the same di-
mension and functionality of the amputated one is formed. In order to do that, genes are
expressed in a pattern that is very similar to that responsible for the limb bud development at
the embryo stage (Knapp et al. 2013). Lineage tracing studies have demonstrated that most
cell types present in the blastema are programmed to differentiate to the same cell type they
are derived from: epithelial cells, muscle cells, nerves, and Schwann cells de-differentiate
during blastema formation, and differentiate again during the formation of the regenerated
limb (Kragl and Tanaka 2009). However, for cells of the connective tissues (lateral plate
mesoderm origin) the same is not true, and any of them can arise from a common progenitor
in the blastema (Gerber et al. 2018). These progenitor cells express Prrx1, a gene that
is expressed in the developing limb bud mesenchyme (Nohno et al. 1993) and is used as
blastema connective tissue progenitor marker gene (Satoh, Makanae, et al. 2011).
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For a correct patterning of the new limb, positional information brought by cells not
implicated in the blastema but surrounding it, is necessary (Endo, Bryant, and David M.
Gardiner 2004). In particular, it is necessary to have enough positional diversity for the
blastema cells to proliferate and give rise to the missing part, gaining more positional identity
going from basal to distal positions (C. McCusker, Bryant, and David M. Gardiner 2015).
Some signalling pathways involved in the process of patterning have been identified, with
retinoic acid inducing cells proximalization by the induction of the proximal determinant genes
Meis1 and Meis2, and FGF inhibiting the action of retinoic acid signalling (Mercader et al.
2000).
Intensive research has gone in clarifying the mechanisms involved in each regeneration
step. Nonetheless, many questions remain open or lack detailed understanding. Among
them, there are two main themes. First of all, the signals secreted by nerves are still not
completely characterized, and their role in multiple aspects of the induction, proliferation
and differentiation of blastema cells is still incompletely understood (Farkas and James R.
Monaghan 2017). Secondly, it has become evident in recent years that the immune system
response after amputation is a major determinant in the differences observed between
regenerating animals, which undergo scar-less healing and subsequent regeneration, and
non-regenerating animals (James W. Godwin and N. Rosenthal 2014; James W Godwin,
Pinto, and N. A. Rosenthal 2013). In this regard, reactive oxygen species (ROS) have
been observed to induce the activation of cell death pathways required for the regeneration.
However, mechanisms to counteract excessive ROS-induced cellular stress are expected to
be in place, in order to protect blastema cells from dying. How a balance between the two
requirements is achieved is still an open question (Love et al. 2013; Tseng et al. 2007; Wang
et al. 2015; F. Zhang, R. Liu, and J. Zheng 2016). Additionally, the adaptive immune system
has been shown to clean up the amputation site in the initial phases, but its role in later
stages of the regeneration is still undefined (James W Godwin, Pinto, and N. A. Rosenthal
2013).
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1.5 Summary
In summary, the ability to induce controlled cellular transitions is important in the context
of disease modelling and treatment, and is necessary for the application of regenerative
medicine to pathological conditions. Additionally, as cellular conversions are involved in
complex processes such as the case of regeneration, it grants the possibility to understand
and reproduce such biological mechanisms.
While computational models for the prediction of transcriptional determinants of cellular
states exist, no such method is available to date for the prediction of signalling determinants.
Acting on the signalling network with chemical compounds, small molecules or growth factors
is particularly interesting because their use is more suited for therapeutical applications and
is safer compared to TF-based experimental strategies. The role of the signalling network
on cellular state is so far analysed independently of the GRN that determines such state.
Thus, this thesis focuses on integrating the signalling and transcriptional regulatory layer in
an ensemble approach for the induction of cellular transitions.
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2 Aims and scope of thesis
The controlled induction of cellular transitions is of interest for disease treatment, regenerative
medicine, and disease modelling. Recently, the possibility of inducing such transitions by
acting on the signalling network garnered more attention, but computational methods for
directing the identification of efficient protocols are needed to ease the temporal and financial
burden of experimental trial-and-error discovery. This thesis proposes predictive methods
that use gene expression data to predict signalling perturbations that can induce cellular
transitions.
The aims of this work are:
• Devise a general approach for the integration of the signalling and transcriptional
regulatory networks, in order to model the effect of signalling molecules and pathways
on GRNs. The two regulatory layers will be modelled separately to take into account
their specificities, and then integrated at the level of interface TFs, which are TFs that
are regulated by signalling and regulate the GRN. The shift between cellular states will
be represented by a transition-specific GRN, while signalling events will be modelled
following a probabilistic approach, in order to account for the inherent stochastic nature
of signal transduction and the uncertainty associated with use of gene expression data
as a measure of signalling activity.
• Develop predictive methods for cellular transitions. Prioritize signalling molecules
according to their potential for inducing the desired changes in the GRN, giving particular
importance to the specificity of their action. Additionally, the predicted molecules will
be associated with signalling pathways to facilitate the interpretation of results in the
context of novel cellular transitions.
• Systematically evaluate the methods on large numbers of datasets and consistently
compare predictions with literature knowledge to assess their relevance to the cel-
lular transitions analysed. The performance of the methods presented will also be
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benchmarked against available tools for the prediction of both signalling molecules and
pathways.
• Apply the methods developed to the analysis of animal models of disease and regener-
ation. Firstly, this integrative approach will be applied to the reversal of a pathological
condition such as cirrhosis, verifying that the candidate signalling perturbations act
on the GRN in predicted ways. Then, it will be used to identify signalling events in-
volved in salamander limb regeneration, a complex phenomenon which requires cellular
transitions at multiple stages.
2.1 Originality
The work presented in this thesis aims at identifying any signalling perturbations that can
induce the transition between an initial and desired cellular state by triggering a shift in the
gene expression program of the cells. This makes this work conceptually different from
previous studies that aim at describing which signalling pathways or molecules are involved
in the observed cellular response to stimuli.
The effective integration of signal transduction and transcriptional regulation allows to
model the action of signalling pathways on an underlying GRN. This goal is achieved by
combining available approaches for GRN and signalling pathways analysis in a new frame-
work, where the signalling and transcriptional regulatory mechanisms are brought together
and integrated at the level of interface TFs, thus permitting the selection of the most suitable
perturbations for the induction of a desired cellular transition.
From the methodological point of view, while computational methods that consider either
GRN or signalling network models are available, the number of approaches trying to integrate
the two regulatory levels is limited. These attempts fall under two main categories: either they
rely on a vast number of data samples, or on manual curation of the integrated networks in
order to accurately capture the effect of signalling cues on gene expression, as described in
Section 1.2.2. The approach presented here, on the contrary, has limited data requirements
and uses widely available transcriptomics data to ensure general applicability and flexibility.
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The main product of this thesis is an approach for the prediction of signalling perturbations
that can induce cellular conversions. Signalling pathways are used to transmit information
from the outside of a cell to the inside in order for the cell to respond to it. Signal transduction
takes place by the interaction of proteins and their exchange of information in the form
of phosphorylation and other covalent modifications, formation of complexes, modulation
of protein localization and stability (M. J. Lee and Yaffe 2016). The signal finally reaches
transcription factors activating or inhibiting them, and therefore exerting control on the cellular
gene expression program.
The proposed framework consists of two regulatory layers: the GRN reflecting the
interplay of TFs involved in the cellular transition regulating each other’s expression, and
the signalling network containing all interactions used for canonical signal transduction. The
GRN is modelled as a Boolean network; the signalling network is modelled by a probabilistic
approach. The difference in modelling approaches is necessary because of the different
levels of uncertainty associated with the use of gene expression data in order to capture
different cellular processes. mRNA abundance has been successfully used to represent
transcriptional activity (H.-C. Chen et al. 2004), and in particular it is widely accepted that a
Boolean representation of TFs activity is able to capture the overall state of large regulatory
networks (S. Huang 1999). The use of mRNA abundance as a proxy for protein signalling
activity however is less straightforward, as gene expression is only weakly correlated with
protein abundance (Pines et al. 2011), and this is in turn not linearly correlated with signalling
activity (Richter et al. 2015). Additional uncertainty is present in signal transduction modelling
because of its stochastic nature, as the physical interaction of the correct proteins in the
cytoplasm against a background of unspecific protein-protein interactions defines successful
transduction (Ladbury and Arold 2012).
The two network models communicate through a layer of TFs that are directly regulated by
canonical signalling pathways, and can regulate other TFs in the GRN. These TFs are here
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termed interface TFs, and represent the point where any signal coming from the exterior of
the cell is de-coded and exerts its action on the cell, by affecting its gene expression program.
3.1 Prediction of signalling molecules for cellular transition
In order to predict which signalling perturbations are able to trigger a desired cellular transition,
a method is developed that identifies which interface TFs can best induce the GRN changes
required for the cellular transition desired, and independently estimates the effect of signalling
molecules on the interface TFs. This two pieces of information are then combined to prioritize
signalling molecules (including plasma membrane receptors, intermediate signalling proteins,
small molecules used in canonical pathways) that specifically act on the most effective
interface TFs, limiting un-specific effects. This first predictive method is called INCanTeSIMO
(Integrated Network approach for Cellular Transitions through SIgnalling MOlecules).
INCanTeSIMO requires gene expression profiles of the initial and desired states, without
relying on a high number of replicates or time-series measurements. It is also independent
from other type of data, such as protein abundance or phosphoproteomics data. This
allows its application to any cellular conversion, including ones that have not been achieved
experimentally.
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Figure 3.1: Overview of the method for the prediction of signalling molecules inducing cellular
transitions. (A) The Boolean GRN containing TFs changing their state during the cellular transition is
connected to interface TFs. All combinations of up to four interface TFs are assigned a fixed state
and the effect of these perturbations on the initial state is assessed. Combinations having the top
three flipping scores (including ties) are selected as the best performing combinations (BPCs). The
frequency of each interface TF state (activated +, inhibited –) across the BPCs is used to calculate the
probability distribution Q of each TF state of causing GRN state changes. (B) The gene expression
probability of each protein is mapped onto the signalling network and defines the signalling interactions
probability. The most probably expressed paths (MPPs) connecting each signalling molecule X to each
interface TF are selected. MPPs probability and sign are used to estimate the probability distribution P
of successfully activating or inhibiting the interface TFs by activating or inhibiting X. Correlation-based
and length-based probabilities are calculated for each couple of signalling molecule and interface
TF (see Methods). (C) The probability distributions Q and P are compared using Jensen-Shannon
divergence (JSD). Perturbations of each signalling molecule are ranked according to this measure.
The best ranking that each molecule perturbation obtains across the correlation-based and length-
based rankings is used as its overall rank. Finally, molecule perturbations ranking in the first fraction
of the final ranking are selected as candidates for the cellular transition.
The method comprises three steps. Initially, the expression state of TFs is Booleanized
and used to represent their activity. TFs showing differential activity in the initial and desired
cellular state are connected by transcriptional interactions from previous knowledge, giving
a transition-specific Boolean GRN.The two cellular states are modelled as separate point
state attractors of the same Boolean network. In this framework, experimental induction of
the cellular conversion corresponds to the induction of the transition from the initial to the final
state attractor, which must be achieved by regulating the state of interface TFs. To select the
most effective interface TFs for this scope, exhaustive perturbations are performed in silico
(Figure 3.1 A).
Independently, the effect of activating or inhibiting each molecule of the signalling network
on the downstream interface TFs is estimated. The minimal condition for signalling interactions
to occur is the presence of the proteins involved in the interaction. The protein availability
can be estimated from gene expression data, as previously done by other methods (Efroni,
Schaefer, and Buetow 2007; Sebastian-Leon et al. 2014). The probability of signal to travel
from a signalling molecule to interface TFs is the probability of all the molecules in the path
connecting them to be present at the same time. In particular, we assume that the signal will
27
CHAPTER 3. MATERIALS AND METHODS
travel along the most probable path available (Figure 3.1 B). Additional assumptions are:
a) genes correlated in gene expression are more likely working together as a signalling
functional unit (R. Huang, Wallqvist, and Covell 2006), thus the probability of their
interaction is higher;
b) the length of the path influences its probability, because the longer a signalling path,
the more chances of off-target interactions (cross-talk) taking place.
These criteria are taken into account in calculating the probability of the most probable
path connecting a signalling molecule to its downstream targets, while the sign of the effect is
given by the sign of the interactions present in the path (Figure 3.1 B).
Finally, for each signalling molecule the Jensen-Shannon divergence is calculated be-
tween the probability of acting on interface TFs and the likelihood of the interface TFs to
induce the required GRN state (Figure 3.1 C). Signalling molecules are ranked according to
the divergence, which privileges signalling molecules acting specifically on effective interface
TFs compared to molecules with unspecific effects.
3.1.1 Gene expression state and probability
All the datasets analyzed in this thesis contain gene expression data obtained by microarray.
For microarray generated on popular platforms, it is possible to apply frozen normalization
approaches and estimate the expression probability using a background distribution (a strat-
egy here referred to as frmaBool). Raw .CEL files were normalized with frozen-RMA (R
package fRMA (Matthew N. McCall, Bolstad, and Rafael A. Irizarry 2010)) and assigned an
expression state using Gene Expression Barcode (Matthew N McCall, Jaffee, et al. 2014;
Matthew N McCall, Uppal, et al. 2011). The barcode approach assumes that normalized and
log-transformed expression values subject to all possible conditions, cell types, tissues and
other biological variables, follow a distribution specific for each probeset in a microarray. This
distribution is approximated as a mixture model of a Gaussian distribution modelling values
corresponding to non-expression, and a uniform distribution corresponding to expression
(Matthew N McCall, Uppal, et al. 2011). The assumption of expressed values following a
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uniform distribution was developed in the analysis of cancer samples, where disruption of
regulation causes the expression values to vary across wide ranges without necessarily in-
forming a biological phenotype (Parmigiani et al. 2002). In this work, the aim is to differentiate
between expression values that correspond to cross-hybridization, and values that represent
real mRNA presence, so the shape of the expressed distribution was kept as simple as
possible. The uniform distribution was considered as it does not require parameters and
is defined as spanning form the mean value of the non-expressed distribution to the value
15, which is the maximum value obtained after fRMA normalization. The non-expressed
distribution for each probeset in each microarray platform, on the other hand, is supported by
two kinds of evidence:
a) S. cerevisiae mRNA: the intensity observed when non-specific transcripts hybridize
with the probes is considered as a measure of the cross-hybridization, and therefore
belongs to the non-expressed distribution (Matthew N McCall, Uppal, et al. 2011).
b) negative controls: it is assumed that each gene will be expressed only in a fraction of
the conditions in which its expression is measured (e.g. only in some tissues or cell
types), so its overall distributions will present multiple modes, and the lowest intensity
mode is expected to correspond to lack of expression (Zilliox and Rafael A Irizarry
2007).
For each gene, the probeset with highest variance was selected. TFs were assigned
Boolean state 1 (expressed) if their assigned value had probability lower than 0.05 of belong-
ing to the non-expressed distribution N(µ, σ), and state 0 otherwise. The values µ and σ
are made available as R Bioconductor packages for microarray platforms Affymetrix Human
Genome U133A, Affymetrix Human Genome U133 Plus 2.0, Affymetrix Human Genome
U133A 2.0, Affymetrix Human Gene 1.0 ST Array, Affymetrix Mouse Gene 1.0 ST Array and
Affymetrix Mouse Genome 430 2.0 Array (Matthew N McCall, Jaffee, et al. 2014).
In this work, an expression probability value was calculated for each gene based on its
29
CHAPTER 3. MATERIALS AND METHODS
most variable probeset x, as follows:
p(x) =
1
2fe(x)
1
2fe(x) +
1
2fn(x)
where fe is the probability density function (pdf) of x in the uniform distribution U(σ, 15),
and fn is the pdf of x inN(µ, σ). Each gene was assigned the maximum expression probability
obtained across all replicates of the initial cellular state.
Intuitively, this formulation assigns expression probability 0 to any expression value ≤ µ,
which is the most frequent non-expressed value, and probability 1 to any value that does not
belong to the non-expressed distribution, independently of the actual value. This agrees with
the idea of not assuming that gene expression levels correspond to protein abundance levels,
a correlation that has been proven non trivial (Edfors et al. 2016; Washburn et al. 2003).
To generalize the previous method to other microarray platforms and potentially RNA-seq
data, colleagues in the Computational Biology group developed a background-independent
approach to calculate expression probability, termed geneDE. Among the differentially ex-
pressed genes (DEGs) between two cellular states, some genes can be expected to pass
from the expressed to the non-expressed state, or vice versa. Therefore, the minimum values
and maximum values observed for each DEG were collected in two separate distributions.
These empirical expressed and not-expressed distributions were then used to calculate the
expression probability according to the formula:
p(x) =
1
2fmax(x)
1
2fmax(x) +
1
2(1− fmin(x))
where fmax(x) is the empirical cumulative density function (ecdf) of x in the maximum
values distribution and fmin(x) is the ecdf of x in the minimum values distribution. Because
some DEGs undergo a change in their expression levels but do not change their state, the
two distributions overlap. The intersection point between the two distributions is used as a
threshold to assign Boolean state: the TFs with average expression value across replicates
lower than the threshold were assigned Boolean state 0, and 1 otherwise.
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3.1.2 GRN reconstruction
TFs that were assigned opposite Boolean state in the initial and final gene expression profile
were assumed to have differential activity in the two states. They were used as seed for
the GRN representing the transition between the two phenotypes. Transcriptional regulatory
interactions among human TFs and other transcriptional regulators as defined in Animal
TFDB 2.0 (L. Zhang, Ng, and S. Li 2015) were collected from MetaCore from Clarivate
Analytics in March 2017. They correspond to interactions labelled with the mechanisms
“Transcriptional regulation”, “Influence on Expression” and “Regulation”; their effect was
“Activation”, “Inhibition” or “Unspecified”.
The literature-supported interactions among the selected TFs were collected in an initial
network, which was then optimized using a previously developed method (Crespo et al. 2013).
Briefly, this algorithm assumes that the cellular states are represented by separate point
attractors in the Boolean network state space. A genetic algorithm that randomly removes
interactions and assigns signs to interactions with unspecified effect is used to make the
attractors state of the network compatible with the gene expression profiles. The simulation of
the network state follows a synchronous update scheme, where all nodes of the network are
updated at each simulation step. The update of each node follows a majority rule, meaning
that the state of the node at the following step is defined by the summation of all active
inhibitions and activations that it receives. The fitness of the resulting network is assessed
by the similarity of the point attractors obtained with the initial and final Booleanized gene
expression state.
A network solution was chosen randomly among the ones that maintain the more edges
and have the least mismatches between simulated data (attractors) and experimental data
(Booleanized gene expression data). Datasets where the resulting GRN contained less than
10 connected TFs were excluded from the study, because they were usually associated with
perturbations not targeting signalling molecules.
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3.1.3 Likelihood of interface TFs to induce the required gene expression
changes
Signalling cues exert an effect on the GRN by controlling the activity of TFs that belong to
signalling pathways and therefore act as signalling effectors. Because signal transduction
is a fast process, acting in a matter of seconds (Kanshin et al. 2015), but the production of
TF protein from the DNA requires dozens of minutes (Shamir et al. 2016), we consider as
available signalling effectors only TFs that are already expressed in the initial cellular state.
In the same vein, the signal will travel along paths composed of proteins already present in
the cell when the cue is applied. Therefore, interface TFs are here defined as TFs that are
expressed at the initial time point, belong to canonical pathways which are expressed (there
is a path composed of expressed genes connecting the TF to any 0-indegree node of the
pathway), and can regulate TFs present in the GRN (GRN-TFs).
Interface TFs are the only way in which signalling cues can act on the GRN in this model,
and their likelihood of inducing the desired changes in the GRN depends on their activity state
and on the GRN itself. Usually, the expression of an interface TFs does not imply it is also
active, as interface TFs are directly regulated by signalling pathways. Only when an interface
TF was initially expressed, but is not expressed in the desired cellular state, we assume that
its expression was associated with activity. In this case, the interface TF is part of the GRN,
and the only perturbation that can be applied to it is inhibition. For all other interface TFs,
both activation and inhibition are in principle possible.
To estimate the effect of each interface TF state on the GRN, in silico simulations were
performed, starting from the initial cell Boolean state. The state of interface TFs singularly
or in combinations of up to four was fixed, and the state of the GRN updated synchronously
following a majority logic rule, until convergence to a fixed-point attractor state. The pertur-
bations were ranked by flipping score, which was defined as the number of GRN-TFs that
assume the final cell Boolean state after simulation. Datasets for which the best flipping score
did not represent the 40% of the GRN-TFs were discarded from further analysis.
In order to prioritize signalling molecules that induce the most effective GRN perturbations,
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combinations of interface TFs not showing any synergistic effects, meaning that the GRN-
TFs they affected were the same as the ones affected by the separate components of the
combination, were discarded. In this way, the scoring of signalling molecules favors more
specific candidates, because the molecules are required to act on few effective interface TFs.
The combinations of interface TFs obtaining the three best flipping scores, including ties,
were selected (best performing combinations, BPCs).
3.1.4 Most probable paths calculation
75 canonical signalling pathways were selected from MetaCore in July 2017, and merged
together in a single signalling network. All interactions reported in MetaCore are the result
expert manual curation of full text papers from literature. The nodes present in the network
represent signalling entities (single proteins or functional complexes), and the interactions
are directed and signed when possible. Edges corresponding to “Technical” or “Unspecified”
effect, and “Technical”, “Transcriptional Regulation”, “Influence on Expression”, “Catalysis”
and “Transport” mechanisms were removed. Further manual curation was also applied to in-
teractions involving TFs known to act as complexes but represented in MetaCore as separate
functional nodes. Edges that were associated with literature not supporting specifically the
direct interaction between a TF and a second molecule were removed (Tables in Appendix
7.1 and 7.2). The final signalling network contained 2496 nodes and 6876 edges. Half of the
nodes belong to more than one pathway, showing the high frequency of cross-talk events
taking place (Figure 3.2).
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Figure 3.2: Overview on the number of canonical pathways to which each signalling molecules belong.
50% of the molecules only belong to one pathway, but others belong to dozens of them.
Signal transduction along any path requires the presence of the proteins that form it,
which is itself dependent on the expression of the corresponding genes. Therefore, the
paths followed by signalling cascades are assumed to depend on the availability of the
corresponding proteins, and the overall effect of a signalling molecule on interface TFs is
approximated by the most probably expressed path (MPP) connecting them. Only directed
paths were considered, meaning that all the interactions follow the same direction, from
molecule to interface TF.
The probability of a path between signalling molecule x and interface TF y is defined as
the probability of all the components of the path being expressed, therefore it is the product
of the expression probability of each of the genes in the path. The probability of the MPP
Mx,y is defined as:
Mx,y = p (MPPx→y) = max p(x→ · · · → y)
where p(x→ · · · → y) = Πjp(j) and p(j) is the expression probability of the intermediate
signalling molecule j in the path connecting x to y.
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Two variations of this approach were considered:
• The longer the path connecting two nodes in the network, the higher is chances that
unspecific or non functional interactions occur. Therefore, the probability of a path was
corrected by its length (measured by the number of interactions l present in the path) by
multiplying it by a factor e(−l) (Jaeger et al. 2014), so that the longer the path, the lower
its probability. The resulting probability was re-normalized across all interface TFs.
• Independently, co-expression has been observed among members of the same func-
tional modules (R. Huang, Wallqvist, and Covell 2006). Assuming that genes with the
same functional properties have common transcriptional regulation, the probability of
interactions between genes that are co-expressed across CMap datasets (absolute
Pearson correlation >0.7 and sign of the correlation matching the sign of the interaction)
was increased. MPPs were calculated using these modified probabilities.
These two corrections were applied independently to the MPP discovery (see Supple-
mentary Information and Figure S4). The distribution of the relative probability with which the
same signalling molecule x acts on all interface TFs (P x) was obtained by:
Px,y =
Mx,y∑
i∈interfaceTFsMx,i
Finally, the sign of each MPP is calculated as:
signx,y =
∏
e=edges∈MPP
sign(e)
If the sign is positive, activating (inhibiting) x results in the activation (inhibition) of TF y
with probability P(x, y). If the sign is negative, activating (inhibiting) of x results in inhibition
(activation) of y with the same probability. Because the MPPs are obtained separately with
correlation-corrected and length-corrected probabilities, two P x and signs exist for each
molecule x.
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3.1.5 Ranking of signalling molecule perturbations
The probability of each signalling molecule to reach each interface TFs is compared to the
likelihood of the interface TFs to induce the desired changes in the GRN state. A high
frequency of a specific activated or inhibited interface TFs among the BPCs suggests that it
consistently alters the state of the GRN, thus for each Boolean state of each interface TF
(TFs-state pair s), the frequency Fs in all BPCs was calculated as:
Fs =
ks
k
where k is the total number of BPCs and ks is the number of combinations where s is
present. The frequencies were normalized across all TF-state pairs, resulting in the probability
distribution Q:
Q =
Fi∑
i∈F Fi
This distribution is compared to the probability of each signalling molecule to act on the
interface TFs P x by Jensen-Shannon divergence:
JSD (Px‖Q) = 1
2
D (Px‖M) + 1
2
D(Q‖M)
where M = 12 (Px +Q) and D(X‖Y ) =
∑
iX(i) log
X(i)
Y (i) (Kullback-Leibler divergence). Both
the activation and inhibition of each signalling molecule are considered. Their divergence
score differ because they have opposite effects on the downstream interface TFs and thus
different effectiveness in changing the GRN state. If for example, the activation of molecule
x activates TF y, which is frequently present in BPCs, the divergence score will be low.
Inhibition of x, however, inhibits TF y, which might not be present in the BPCs. Thus, the
probability of reaching TF y is the same, but the resulting ranking is different for the two
perturbations applied to molecule x.
The signalling molecules were sorted by their divergence, where lower divergence corre-
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sponds to better ranking, and assigned rank R(x):
R(x) = min rankv∈Px(x, v)
where rank(x, v) is the rank obtained by the molecule x in the variant v of the MPP calculation,
using either correlation- or length- corrected probabilities.
Different cut-offs, defined as fractions of the maximum R value present in the final ranking,
were considered (from 1 to 10%). Signalling molecules whose rank was lower than the
cutoff were selected as candidates for the induction of the cellular transition considered. The
prediction was considered successful if at least one of direct targets of the experimental
perturbation was selected among the candidates, similar to (K. Chen and Keaney 2012). The
optimal cut-off was selected as the one having maximum improvement compared to random
chance of success across the datasets from CMap. This was calculated as the probability of
selecting at least one perturbation target in a randomly chosen list of the same size, by using
one-sided hypergeometric test.
3.1.6 Functional measures
The list of candidate signalling molecules was tested for functional and topological features.
First, the enrichment in Gene Ontology (GO) biological process terms was calculated for
both candidate and non-candidate signalling molecules with the use of R package gProfilerR.
The GO terms associated to the targets of the experimental perturbations were collected,
and their overlap with enriched terms in the candidate and non-candidate molecules list was
calculated across datasets. The distributions obtained were compared by one-sided Wilcoxon
test (p-value <.05).
The distance of candidate signalling molecules from the direct targets of experimental per-
turbations was calculated along the signalling network, taking into account the directionality of
the interactions. Each candidate was assigned an out-distance and an in-distance, depending
if the perturbation targets were reached by following edges downstream or upstream. The
smallest of the two distances was then selected, and the average distance of each candidate
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to all reachable perturbation targets was calculated. The average distance from perturbation
targets was calculated in the same way for non-candidate molecules. The distributions of
average distances for candidate and non-candidate signalling molecules were compared by
Wilcoxon test with 100’000 Monte Carlo replicates (p-value <.05).
3.2 Prediction of signalling pathways for cellular transitions
In the case of novel systems or transitions, interpretation of the list of single molecule candi-
dates can be complicated. As development, differentiation and other biological processes are
driven by the concerted action of signalling pathways, one could argue that the prediction
of canonical pathways is particularly relevant for these applications. The majority of the
existing pathways analysis methods look at differential activity state between two cellular
contexts, while only very few search for pathways that mediate the transition between these
contexts (Y.-A. Kim, Wuchty, and Przytycka 2011; Melas et al. 2015; Paull et al. 2013). These
methods aim at finding the most suitable network to connect a causal set of genes, such as
disease or mutated genes and known drug targets, to a target set, composed of DEGs. The
limited available information on the paths effectively used means that the evaluation of these
methods is done by comparison of the causal networks obtained with canonical pathways.
We therefore extended our method from the prediction of single signalling molecules, to the
prediction of the activation or inhibition of canonical pathways that can drive cellular transition.
This extension is here termed INCAnTeSIMO path.
3.2.1 Pathways prediction
For each signalling pathway present in the signalling network, the inhibitors of the pathway
were identified as the nodes that have both incoming and outgoing inhibitory interactions.
This is because in the canonical pathways considered inhibitors are associated with their
own inhibitors, so that the overall outcome of the pathway is activatory. Then, two separate
signalling gene sets were prepared for each pathway: one activatory set with all active
effectors of the pathway and the inhibition of its inhibitors; and one inhibitory set containing
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the inhibition of its effectors and the activation of its inhibitors.
As the candidates were ranked according to their specificity in inducing the desired GRN
perturbations, it is not expected that all signalling molecules belonging to a pathway perform
equally. However, if molecules that are particularly influential in a pathway are predicted, the
whole pathway can be expected to induce similar effects on the GRN and therefore induce
the same cellular transitions. Network centrality measures express how important particular
nodes in a graph are to its connectivity, and multiple definitions are used (Newman 2010).
Here, the signalling gene sets were tested for significance in the list of candidate signalling
molecules according to the concept of source/sink centrality (Naderi Yeganeh and Mostafavi
2019). Source/sink centrality is a topological property of network nodes that depends on the
number of directed paths inside a signalling pathway that are incoming and outgoing of each
node, and the length of such paths. It is calculated by (Naderi Yeganeh and Mostafavi 2019):
CSSC(v) = Csource(v) + βCsink(v) =
∑
wj :vu-walk of G
α|wj | + β
∑
wj :uv-walk of G
α|wj |
where v is the node in the pathway graph G considered, u is any other node in G, wj is an
incoming or outgoing path connecting v to u and |wj | is its length, α is a dampening factor
that decreases the contribution of longer paths to the overall measure (here α=0.1), and
β indicates the relative importance of the source and sink components (here β=1) in the
centrality score. CSSC(v) represents the importance of the node v as sender or receiver of
information in the pathway considered.
In the original implementation, an enrichment score is obtained by calculating the ag-
gregated importance of DEGs, and a statistical significance is assigned using a bootstrap
sampling approach. Here, the aggregated importance of signalling molecule candidates
obtained from INCAnTeSIMO U is calculated by:
Agg(U) =
∏
ui∈U
CSSC(ui)
The probability of observing a higher aggregate score for a randomly selected subset of
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G is used as the p-value for each pathway.
3.3 Comparison with existing methods
The methods proposed here were compared with computational approaches developed
previously to predict signalling molecules or pathways related to the differences between two
cellular states. None of them was specifically developed to identify signalling perturbations
to induce the conversion between an initial and final cellular state. CMap (Subramanian,
Narayan, et al. 2017) and DeMAND (Woo et al. 2015) are intended for the prediction of
perturbations on single signalling molecules, while pathway enrichment methods considered
were over-representation analysis, GSEA (Subramanian, Tamayo, et al. 2005), SPIA (Tarca
et al. 2009) and CADIA (Naderi Yeganeh and Mostafavi 2019).
3.3.1 Single molecule prediction
Initially, differential expression analysis was compared with INCAnTeSIMO. Differential gene
expression between the initial and final expression profiles was calculated with the R package
limma. Genes showing absolute log fold change (lfc) > log2(1.5) and having Benjamini-
Hochberg (BH)-adjusted p-value <.05 were considered differentially expressed. If replicates
were not present, the lfc cut-off alone was applied. Signalling molecules were ranked
according to decreasing absolute lfc values to generate their ranking by differential expression.
Connectivity map (CMap) (Subramanian, Narayan, et al. 2017) allows to query a gene
expression signature against a database composed of chemical and genetic perturbations
applied to different cellular types. It uses the ranking of genes according to log fold change
to match known perturbation profiles to the query, which are then returned as predictions.
DEGs were selected (BH-adjusted value<.05 or absolute lfc > log2(1.5) if replicates were
missing). DEGs were sorted separately for up- or down-regulation by decreasing absolute lfc,
and up to 150 genes for each class were submitted to the Batch query functionality of CMap
L1000 query (Subramanian, Narayan, et al. 2017)), using the option sig fastgutc tool. CMap
perturbations were considered correct if any of the direct experimental perturbation, its direct
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targets, or alternative drugs acting on the same targets were assigned a connectivity score
(tau)>90 in the summary results across all cell lines. Datasets with less than 10 DEGs or
raising errors during submission were discarded.
DeMAND (Woo et al. 2015) is a method for predicting genes associated with the mode of
action of a drug or compound. It scores each gene based on how significantly the expression
of its targets is dysregulated following the application of a drug. It relies on context-specific
regulatory networks representing both direct and indirect transcriptional regulation. Given its
requirements for numerous replicates, DeMAND could not be applied to datasets used to
evaluate the proposed method, so the opposite strategy was followed. The method presented
here was applied to the GEO13 datasets present in the original DeMAND study (Woo et al.
2015). Only Affymetrix datasets were considered, using either the barcode strategy presented
in Section 3.1.3, or the MAS5.0 detection call approach described later in Section 3.4. Genes
assigned FDR≤.1 were considered predicted. Successful predictions were defined as the
ones that recover perturbation direct targets as determined from STITCH, DrugBank and the
original study.
3.3.2 Pathway prediction methods
Pathway enrichment in DEGs tests if the genes associated to a particular pathway are
over-represented in the list of DEGs. Gene set enrichment analysis (GSEA) (Subramanian,
Tamayo, et al. 2005) calculates a pathway-level score by considering not only if DEGs belong
to a pathway, but also their log fold change. Therefore, it tests if the genes belonging to a
pathway are enriched in the ordered list of DEGs, either at the lowest lfc (meaning among
the down-regulated genes), or in the highest lfc values (meaning they are up-regulated).
MetaCore pathway enrichment was calculated by one-sided hypergeometric test (BH-adjusted
p-value<.05). Pathway enrichment and GSEA were applied to the signed signalling gene
sets corresponding to MetaCore signalling pathways defined in Section 3.2.1 using the R
package clusterProfiler (Yu et al. 2012).
SPIA (Tarca et al. 2009) analysis combines classical enrichment analysis with expression
changes that are propagated across the topology of KEGG pathways. DEGs were selected
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(BH-adjusted value<.05 or absolute lfc>log2(1.5) if replicates were missing). KEGG signalling
pathways were scored using R package SPIA. If any of the significant pathways contained
direct targets of the perturbation, the prediction was considered successful. Datasets where
no DEGs were found were discarded.
Causal disturbance analysis (CADIA) (Naderi Yeganeh and Mostafavi 2019) considers
not only the topology of KEGG pathways, but also the directionality of interactions. In it,
the concept of source/sink centrality is combined with classic pathway over-representation
analysis (ORA) to derive a pathway enrichment score based on DEGs. The R package
CADIA was used to calculate a causal disturbance score (cadia) for each pathway, using
parameters α=0.1 and β=1. Pathways with cadia≤0.05 were considered as candidate
pathways. Pathways enriched in aggregate importance of the DEGs were also selected
(PSSC ≤ 0.05), and are referred to as SSC DEG.
INCAnTeSIMO path was compared also with alternative approaches using INCAnTeSIMO
candidate molecules to predict signalling pathways, namely CADIA and over-representation
analysis (ORA) on MetaCore pathways. Regarding ORA, each signalling gene set was tested
for enrichment in the single molecule candidates against a background composed of all the
signalling molecules connected to the GRN. Then, the gene sets was tested for enrichment
in the single molecule candidates against a background composed of all the molecules in
the complete signalling network. The two backgrounds can vary significantly depending on
the GRN, so this ensures that the over-represented signalling gene sets are as a whole able
to act on the GRN, and their components can induce the desired cell fate conversion. Both
tests were performed using one-sided Fisher exact test with FDR correction, and gene sets
enriched for both tests (FDR≤0.05) were retained. In CADIA, the original method proposed
in (Naderi Yeganeh and Mostafavi 2019) was adapted to use candidate molecules instead of
DEGs and predict signed MetaCore pathways instead of KEGG pathways (cadia score≤0.05).
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3.4 Application to a cirrhotic animal model
Expression data for healthy liver of male Wistar rats was extracted from GEO dataset
GSE71201. Cirrhosis was induced in 10 male Wistar rats by exposure to inhalation of CCl4,
as previously described (Tsuchida and Scott L. Friedman 2017) and in accordance to the
criteria of the investigation and ethics committee of the Hospital Clı´nic Universitari and the
University of Barcelona. Five cirrhotic rats were treated with 10 mg/kg of CVX-060 (Pfizer,
Inc., New York, NY, USA) diluted in 500 µl of saline solution and injected intravenously via the
tail vein, once a week for 4 weeks. Gene expression of CCl4 and CCl4+CVX-060 -treated
livers was obtained with microarray (Affymetrix GeneChip Rat Genome 230.2 Array). These
experimental procedures were performed by collaborators at the Hospital Clı´nic in Barcelona.
Two replicates for each treatment were kept after quality control and PCA visualization.
For the prediction of signalling molecules, gene expression data of the cirrhotic and
healthy liver was used. Gene expression probability was assigned to each gene according to
1− p, p being the p-value obtained from Affimetrix MAS5.0 detection call (Affymetrix 2002).
If the expression probability ≥0.94 (corresponding to a “marginal” or “present” call from
MAS5.0), the gene was considered expressed, and not-expressed otherwise.
The predicted GRN state after CVX-060 treatment was obtained by selecting all interface
TFs activated or inhibited by the activation of Tie2 with probability higher than zero, according
to the calculation of the MPPs. The BPCs containing only combinations of such interface TFs
were selected, and the GRN-TFs that change their state in response to them are expected to
change upon CVX-060 application. The GRN state predicted after the inhibition of Ang2 was
obtained in the same way.
3.5 Application to an animal regeneration model
This section presents methods specific for the application of the method to the prediction of
pathways involved at each time step of a limb regeneration time series in the salamander
Ambystoma mexicanum. The following procedures were performed by collaborators at the
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Research institute of Molecular Pathology (IMP), at the Center for regenerative Therapies
Dresden, and in the Computational Biology research group at LCSB.
3.5.1 Experimental procedures
Time-course includes time points: 0, 1, 3, 5, 7, 10 and 14 days following upper-arm amputation.
Tissue between 0.5 mm behind the amputation plane and the tip of the blastema was collected.
Connective tissue progenitors were specifically and irreversibly labeled during the limb bud
development via Cre-induced recombination of a reporter construct. Connective tissue
specificity is achieved by the Prrx1 –limb specific enhancer that controls the expression of
the Cre recombinase in the transgenic axolotls. Upon Cre activation using drug Tamoxifen,
a DNA-cassette is removed from the reporter-transgene allowing the expression of the
red fluorescent protein Cherry. Cherry+ cells were selected using fluorescence-activated
cell sorting. RNA was extracted and reverse transcribed. The resulting cDNA was then
transcribed into labeled complementary RNA (cRNA) which was hybridized to custom Agilent
2x400K oligonucleotide microarrays.
3.5.2 Data processing
Probes showing low gene expression correlation across replicates were excluded from further
analysis. When multiple probes were mapping to the same gene, the mean of the highly
correlated probes (Pearson correlation >.8) was assigned to the gene. Differential expression
analysis was performed with the R package limma for each couple of consecutive time points
(i.e. D1 vs. D0, D3 vs D1, etc.), and genes were considered differentially expressed with
absolute log fold change higher than log2(1.5) and p-value corrected for false discovery
rate (Benjamini and Hochberg 1995) lower than 0.05. The Boolean state and expression
probability was calculated at each time point with the geneDE approach described in Section
3.1.3.
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3.5.3 GRN reconstruction
An initial GRN for axolotl was inferred from the microarray data using five different GRN
inference tools: CLR (Faith et al. 2007), TIGRESS (Haury et al. 2012), PLSNET (Guo et al.
2016), GENIE3 (Huynh-Thu et al. 2010) and Pearson’s correlation coefficient. The inference
was performed for TFs differentially expressed and changing their Boolean state at any time
interval. All tools were used with default parameters. The results of the different methods were
combined by keeping interactions that were ranked among the best 10% of all interactions,
by at least four of the five used tools. The sign of the interaction was assigned according to
the results of Pearson’s correlation: if the correlation is negative, the interaction is deemed
inhibitory, otherwise activatory. For each time interval, a subnetwork was extracted containing
only TFs that are DE and changing their Boolean state in that time interval. Each subnetwork
was optimized as mentioned in Section 3.1.2, resulting in GRNs specific for each time step of
the regeneration time course. In order to confirm that TFs relevant to the biological processes
involved in regenerations are captured during the GRN inference process, enrichment in
Gene Ontology terms related to Biological Processes was tested. The R package topGO
(Alexa, Rahnenfuhrer, and Lengauer 2006) was applied using algorithm “weight01” and
Fisher test statistics.
3.6 Databases
3.6.1 Perturbation targets
The protein targets for drugs and small molecules used in the experiments were obtained
from STITCH ((Szklarczyk et al. 2016), v5.0, accessed in October 2017, with experimental
evidence confidence >0.4). The effect of the perturbations on their targets (activation,
inhibition, or unknown effect) was extracted from DrugBank ((Wishart et al. 2018), accessed
in October 2017) and MetaCore from Clarivate Analytics.
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3.6.2 Pathway targets
The experimental perturbations collected were rarely directed to the perturbation of complete
canonical pathways. Therefore, the pathways that should be recapitulated by predictions
were not defined beforehand. To do so, the pathways that contained at least 25% of the direct
perturbation targets were selected. Additionally, if any of the direct targets only belong to one
canonical pathway, that was also retained as positive pathway. This procedure was applied to
both Metacore pathways, as defined in 3.2.1 and to KEGG pathways.
3.6.3 Datasets
Datasets where gene expression data was measured by microarray before and after the appli-
cation of a signalling perturbation were collected across different databases. In particular, all
datasets present in Connectivity Map (build 02, (Lamb et al. 2006)) generated on the platform
Affymetrix Human Genome U133A 2.0 Array were considered. Then, manually selected
experiments where a single perturbation was applied were collected from ArrayExpress
and Gene Expression Omnibus. All experiments whose perturbation targeted molecules
absent from the signalling network or disconnected from interface TFs were removed, as
well as chemically undefined perturbations (culturing with other cell types, ROS and other
cellular stressors, use of serum, etc.). The analysis was then restricted to datasets where the
perturbation applied targeted up to 30 signalling molecules present in the signalling network,
in order to test the methodology developed on well-characterized signalling perturbations
and avoid obtaining correct predictions by chance. In particular, experiments related to
cell differentiation and reprogramming of non-cancerous cell types were used to test the
prediction of both signalling molecules and pathways to induce cellular transitions (Table in
Appendix 7.3).
3.6.4 Phosphoproteomics datasets
Phosphoproteomics experiments where a single perturbation was applied to the cells were
collected. They were paired with gene expression datasets with closely matching initial
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Table 3.1: Phosphoproteomics datasets considered. The log fold change used in the original study
to define differentially phosphorylated (DP) proteins is reported (DP lfc). The number of interface
TFs that are connected to the GRN (selected) and DP is reported for comparison with the number
of selected or DP interface TFs. The enrichment of the selected interface TFs in DP proteins was
calculated by one-sided Fisher test.
Dataset Cell
type
Perturbation DP lfc sel.
DP
iTFs
sel.
iTFs
DP
iTFs
p-value
D’Souza et
al. 2014
HaCaT TGF-β 1 18 59 51 2.36E-04
Sharma et
al. 2014
HeLa EGF 1 19 30 139 3.24E-03
Wilkes
et al. 2015
MCF7 EGFR inhibition
[EGFR2]
1 16 60 52 4.13E-03
Gnad, Doll,
et al. 2016
HCT116 MAPK inhibition
[GDC0973 (1µM)]
log2(3) 3 29 15 1.08E-01
Rudolph et
al. 2016
MCF7 EGF 2.38 1 27 2 1.43E-01
Wierer et
al. 2013
MCF7 estradiol log2(1.5) 0 57 3 1.00E+00
conditions and perturbation applied. When possible, the same cell type was perturbed with
the same chemical compound in both phosphoproteomics and transcriptomics datasets,
and the delay before measurements was comparable. Otherwise, a delay of up to 48 hours
was considered. Closely related cell lines and equivalent perturbations (acting on the same
protein targets) were accepted. The list of differentially phosphorylated (DP) proteins were
obtained directly from the original phosphoproteomics studies, when available, or extracted
by repeating the analysis as described by the authors (Table 3.1). Each protein was assigned
the highest log fold change observed for any of its phosphosites.
3.6.5 Availability
The methods were implemented as a Snakemake pipeline (Koster and Rahmann
2012), consisting of Matlab and R scripts, and was made available at https://git-
r3lab.uni.lu/gaia.zaffaroni/INCanTeSIMO. Microarray data generated in the context of the
application to cirrhosis is available in Gene Expression Omnibus under accession number
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GSE122822. The analysis of all datasets was performed on the UL HPC platform (Varrette
et al. 2014).
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4 Results
In this chapter, the performance of INCanTeSIMO and INCanTeSIMO path is assessed across
numerous datasets obtained from different sources. Additionally, their predictions in examples
of cellular differentiation and reprogramming are compared with literature knowledge. Finally,
they were applied to the analysis of animal models of disease and regeneration.
4.1 Comparison of MPPs with phosphoproteomics data
Protein regulation in signalling pathways takes many forms (M. J. Lee and Yaffe 2016),
but phosphorylation takes a prominent role as the primary mechanism used to transmit
signal in the cytoplasm. For this reason, phosphoproteomics experiments are used to infer
protein activity in response to signalling cues (Invergo and Beltrao 2018). Proteins showing
significant changes in their phosphorylation state are expected to play an active role in
the transmission of the signal, so that signalling paths responding to a stimulus show an
enrichment in differentially phosphorylated (DP) proteins compared to paths that are not
involved. Under this assumption, the most probably expressed paths (MPPs) identified with
INCanTeSIMO were tested for enrichment in phosphorylation changes.
Previously published experiments, measuring gene expression and phosphoproteomics
data before and after a specific perturbation was applied, were collected (Table 3.1). For
each of them, the direct perturbation targets were defined from databases, and the interface
TFs available were identified as described in the Methods section 3.6. The interface TFs
selected were significantly enriched in DP TFs, when the number of DP TFs was high (Table
3.1). The MPPs between each target and interface TF pairs were computed using both the
correlation- and length-corrected probability as defined previously.
Signalling proteins can contain multiple phosphosites, which are amino acids that can be
modified by the addition of a phosphate group. Phosphorylation of each site might or not have
a functional role, by modifying the way the protein can interact with its partners (M. J. Lee
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and Yaffe 2016). At the moment, the annotation of functional sites is available for a limited
number of proteins, while for the vast majority of proteins this information is still not available
(Invergo and Beltrao 2018). Thus, any significant change in the phosphorylation of a site was
assumed to be functional, and a protein was considered DP if any of its phosphosite resulted
DP in the original publications (Table 3.1).
The frequency of DP proteins in each MPP was compared to up to 100 randomly selected
simple paths connecting the same source and target signalling nodes (corresponding to
perturbation target and interface TF, t-test with p-value < 0.05) (Figure 4.1A). Overall the
majority of the MPPs for each dataset had more DP proteins than other possible paths, for
both methods used to define MPPs (Figure 4.1B), even if some particular target-interface TF
combination was connected by paths that did not contain any phosphorylated protein (Figure
4.1C).
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Figure 4.1: Enrichment of MPPs in differentially phosphorylated (DP) proteins. (A) MPPs are defined
by both correlation-based and length-based probabilities from the perturbation targets to all interface
TFs. For both methods, the fraction of DP proteins in each MPP connecting each target-interface
TF pair is compared by t-test to the number of DP proteins in up to 100 randomly selected simple
paths connecting the same pair. (B) Average fraction of MPPs significantly enriched in DP proteins
compared to alternative simple paths, per dataset (P-value < 0.05). (C) Breakdown of the results for
each perturbation target. Orange: number of interface TFs for which the fraction of DP proteins in the
MPP is significantly higher than in other simple paths. Light-blue: interface TFs reached with MPPs
that show no significant difference in DP enrichment; grey: interface TFs that are connected to the
perturbation target with paths (both MPPs and alternative paths) that do not contain DP proteins. The
same results (panels B and C) were obtained with both correlation-based and length-based MPPs.
These results show that using MPPs to represent the signal transduction from signalling
molecules to interface TFs is in agreement with observed phosphorylation patterns. This
suggests that MPPs can be used as approximation of paths used for signal transduction.
4.2 GRN perturbation results
In general, a limited number of TFs was observed to change their Boolean state between the
initial and final cellular state, so the size of the GRNs representing the cellular conversion
was moderate (on average 24 TFs, Figure 4.2A). The number of interface TFs selected for
each dataset was highly variable, ranging between 12 and 151 and averaging 39 TFs. The
best perturbation in each dataset was able to change the Boolean state of 71% of the GRN
TFs on average.
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Figure 4.2: Effect of the in silico perturbations of combinations of interface TFs on the state of the
GRN. (A) The percentage of GRN-TFs that change their state in the best combination overall is
represented. (B) The performance of interface TF combinations that obtain the first, second and third
flipping scores, compared to the average flipping score obtained with all the combinations tested,
represented by distance measured in number of standard deviations from the average. The black line
represents 2 standard deviations from the average.
The best performing combinations (BPCs) were selected by considering the combinations
obtaining the best three flipping scores. This corresponds to combinations that are overall
more than 2 standard deviations away from the average flipping scores obtained in each
dataset (Figure 4.2B).
4.2.1 Effect of the number of targets on the effect of interface TFs on the GRN
state
The influence of the number of targets of an interface TFs on its frequency among the BPCs
was analysed. There was a general tendency of interface TFs with more targets to be present
among the BPCs in more datasets (Figure 4.3). However, no single interface TF was present
in the BPCs of all datasets, and even interface TFs with more than 100 targets were present
in the BPCs of as low as 10-20% of all datasets.
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Figure 4.3: Effect of the number of transcriptional GRN-TFs that are targets of each interface TF
(x-axis) on the frequency of an interface TF state among the BPCs of multiple datasets (y-axis). 538
interface TF states are present across the 228 datasets considered.
This result is not surprising. The expression of the interface TFs in the initial cellular state
and the expression state of the cell in general influence the set of interface TFs considered.
Additionally, each cellular transition is assigned a different GRN, containing a distinct set of
differentially expressed TFs. Therefore, the same interface TF will have different targets in
each dataset, and different effectiveness in changing the state of the corresponding GRN. As
a result, the presence of an interface TF among the BPCs cannot be estimated a priori.
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4.2.2 Synergy among interface TFs
Before selecting the BPCs, combinations of interface TFs that did not show any synergistic
effect were discarded. The rationale behind this choice is to limit the number of interface
TFs that the ideal signalling molecule should act on, in order to prioritize specific GRN
perturbations. In fact, small molecules or drugs with a limited number of targets are generally
preferred to compounds that have unspecific effects on cells. Selecting BPCs that showed
some synergistic effect, the number of interface TFs to perturb was reduced (Figure 4.4),
while the GRN state changes they are predicted to induce was maximised.
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Figure 4.4: Effect of filtering for synergistic effect on the number of interface TFs in the BPCs. The
fraction of interface TFs connected to the GRN that are present in the BPCs is shown for each dataset.
BPCs are selected by a) considering all combinations with the three best flipping scores (“unfiltered”,
blue); b) by considering the combinations with synergistic activity of the involved TFs, so that the
combination is affecting the state of more GRN-TFs that the sum of its components (“filtered”, red).
Apart from two cases, the filtered BPCs contain an equal or lower fraction of interface TFs compared
to the unfiltered BPCs.
The success rate of INCanTeSIMO in predicting direct targets of the experimentally applied
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perturbation was 61% when ranking signalling molecules by their probability of activating
the interface TFs present in synergistic BPCs. In order to test if this filtering had a positive
influence on the overall method performance, the success rate was calculated when all BPCs,
without filtering for synergistic combinations, were considered. The performance obtained
was 56%. The difference bewteen the two was not large, but nonetheless showed that
predictions improved when only synergistic combinations of interface TFs were considered.
It must be noticed that focusing on synergistic combinations did not result in selecting
“rare” interface TFs, defined as TFs that are present in less than 1% of the BPCs of a certain
cellular transition. In fact, BPCs composed of only rare TFs represented only 0.006% of
the BPCs across all datasets. This indicated that BPCs are composed mostly of ”common”
interface TFs, while it hardly happened that a specific combination of otherwise non-effective
interface TFs resulted in large GRN state changes. Enumerating all combinations of interface
TF states is unfeasible, but this pattern was assumed to exist in higher order combinations
too, so that almost exclusively ”common” TFs would be present in BPCs. Thus, the frequency
of interface TF across BPCs was used as a measure for its effectiveness in changing the
GRN state as desired, independently from the perturbation size considered.
4.3 Overall performance in the prediction of signalling
molecules for cellular transitions
INCanTeSIMO was applied to single drug perturbations applied to cell lines, obtained from
CMap and ArrayExpress. After quality controls, 228 datasets (193 from CMap, 35 from Array-
Express), corresponding to cellular transitions, were analysised. The signalling molecules
were ranked by calculating the Jensen-Shannon divergence between their probability of
acting on interface TFs, and the likelihood of interface TFs to induce the desired GRN state
transitions (see Materials and Methods). For each dataset, 1400-1500 signalling molecules
were tested for both their activation or inhibition, for a total of around 3000 potential signalling
perturbations. The ranking prioritized molecules that reach with high probability and specificity
interface TFs that performed well in the in silico perturbations of the GRN.
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Initially, the ranking obtained with INCanTeSIMO was compared with simple differential
expression analysis: genes were sorted by decreasing absolute lfc, an increasing part of
the ranking was selected and the datasets for which perturbation targets were found in the
selection were counted. Ranking by differential expression did not prioritize perturbation
targets, which were only found after a big portion of the ranking was selected (Figure 4.5A).
The ranking generated by INCanTeSIMO performed better: to select at least one correct
perturbation target in 50% of the datasets, 920 molecules should be selected according to
differential gene expression, and 236 are necessary with INCanTeSIMO. This result confirms
that differential expression is not informative on the role of genes in signal transduction, and
therefore the use of more complex approaches is required to extract meaningful predictions
from gene expression data.
The success rate of a method predicting signalling molecules for cellular transitions was
defined as the fraction of datasets for which a correct prediction was obtained. As each
cellular transition was obtained experimentally to generate the data analysed, a prediction
was considered correct if at least one of the known targets of the experimental perturbation
appeared in the top ranked molecules. At different ranking cut-offs, INCanTeSIMO success
rate was better than the expected by random selection of the same number of molecules
(Figure 4.5B). Cut-off=0.06 was used for following analyses because the gain of performance
of INCanTeSIMO compared to random selection was maximum, with successful predictions
in 139 out of 228 datasets (61%)(Complete table in Appendix 7.3). At this cut-off, the method
correctly predicted perturbation targets in 115/193 CMap examples (60%, versus random
success rate of 40%), 6/10 datasets for non-cancer cell lines selected from ArrayExpress,
5/6 datasets with matched phosphoproteomics data, and 13/19 cell type transitions datasets
(discussed below).
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Figure 4.5: Overall performance of INCanTeSIMO in predicting direct perturbation targets. (A) Fraction
of datasets with at least one perturbation target correctly predicted, across increasing selection of
ranked molecules. The proteins were ranked either by INCanTeSIMO, or by differential expression
analysis (log fold change). (B) Variation of success rate and number of selected signalling molecules,
at different ranking cut-offs. Circles=INCanTeSIMO success rate, X=success rate for random selection
of the same number of molecules. Horizontal error bars: 5th and 95th percentile of selection size. To
the same fraction of ranking selected correspond variable set sizes because of ties in the ranking. The
selection of 6% of the ranking gives the best improvement compared to random performance. Only
CMap datasets where used to define this cut-off.
4.3.1 Factors influencing the performance
The probability of finding at least a direct perturbation target among the candidate molecules
depends on their number. Therefore, datasets were divided in classes according to the num-
ber of targets that the applied perturbation (compound or protein) has across the databases
used (see Methods section 3.6.1). The performance of INCanTeSIMO was assessed in each
of the classes obtained by comparing the observed success rate to the frequency at which a
target is expected to be selected by random selections of the same size (Figure 4.6). The
method was significantly better than random in datasets with 1 to 10 known perturbation
targets (p-value=1.27e-04 for datasets with 1-5 targets, and 9.40e-06 for 6-10). These
datasets represent the 74% of all tested datasets and also correspond to the most interesting
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application cases, as the use of target-specific drugs or proteins is preferred for the controlled
induction of cellular transitions.
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Figure 4.6: Prediction of signalling molecules compared to expectation, according to the number of
known perturbation targets. The datasets were divided in classes according to the number of direct
perturbation targets, and the expected success rate was calculated for each dataset depending on
the number of targets and the number of candidates selected by INCanTeSIMO (light blue dots). The
fraction of datasets in each class where INCanTeSIMO predicted correctly at least one perturbation
target is depicted with short red bars. The overall success rate of INCanTeSIMO (red dotted line, 61%)
and the overall expected success rate (blue dotted line, 39%) are reported.
The number of DEGs between in initial and final cellular states was significantly higher for
datasets in which INCanTeSIMO obtained correct predictions (Figure 4.7, p-value=5.032e-06).
This result suggests that the method is particularly suited for cellular transitions that require
extensive gene expression changes, not only for the TFs in the GRN, but also of the genes
that they regulate. In other words, the bigger the differences between the initial and final gene
expression state, the more likely it is that perturbations of the GRN via signalling perturbations
can effectively induce the transition. On the contrary, when only limited differences are present
between the initial and desired gene expression profile, acting on the GRN might not be the
most effective strategy, and punctual regulation of the expression of single genes might be
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more indicated.
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Figure 4.7: Success of the signalling molecule predictions with respect to the difference between initial
and final cellular states. In datasets where INCanTeSIMO obtained successful predictions, the number
of differentially expressed genes between the two gene expression profiles was significantly higher
than in the datasets where the predictions were not correct (one-sided Mann-Whitney test, p-value =
5.032e-06).
The vast majority of the perturbation-target pairs present in the analysed datasets do
not have a defined sign (Figure 4.8). For the 18% of the pairs that do have signs, the
perturbation plays predominantly an inhibitory role on its targets (69%). Among the predictions
obtained with INCanTeSIMO there was no bias in the sign of the candidate molecules, but
the predominance of inhibitors among the perturbations was correctly reflected in the higher
percentage of inhibitory molecules correctly predicted (69%). Nonetheless, errors in the
predicted sign might occur in the predictions. This can be explained by the fact that multiple
equally probable paths with opposite signs might exists between two nodes in the signalling
network, but only one MPP is selected as representative of the effect of a signalling molecule
on an interface TFs, thus determining the selection of the activation or inhibition of the same
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Figure 4.8: Effect of experimental perturbations on their protein targets. The vast majority of the drug-
target pairs present in the datasets analysed and contained in the signalling network (“perturbation
targets”) is unsigned across multiple databases. Of the known interactions (“signed targets”), 69% are
inhibitory. In the predictions obtained with INCanTeSIMO (“predicted molecules”), there is balance
between activations and inhibitions, and the correct predictions show the same fraction of inhibitions
as observed across all known interactions.
The effect of signalling molecules on the interface TFs are calculated using both length-
based and correlation-based interaction probabilities. The two measures are moderately
predictive taken separately: both of them predict around 43% of the datasets correctly at
cut-off=0.06. The combination of the rankings obtained with the two strategies however
resulted in a limited number of ties and better predictions overall. The influence of the
two approaches on the predictions is similar: among the datasets associated with correct
predictions mentioned previously (61% of the total 228 datasets), 37% would be correctly
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predicted with any of the two probability strategies, 31% require length-based probabilities,
and the remaining 31% stems from correlation-based probabilities. Thus, there is not a single
strategy that is best for the inference of signal transduction paths, as it seems that both
co-expression of the proteins that need to interact, and the number of interactions overall,
play a role in the choice of signal transduction paths used.
4.3.2 Functional and topological properties of candidate molecules
Apart from the perturbations experimentally tested, the perturbation of other signalling
molecules might trigger the desired cellular transitions. For example, molecules that are
involved in the regulation of the same biological processes as the experimental perturbation,
or molecules that are positioned in their vicinity in the signalling network. Therefore, the
sets of predicted candidate signalling molecules were tested for their relatedness to direct
perturbation targets in terms of functional annotation and distance from the experimental
targets.
Functional analysis was performed by Gene Ontology (GO) analysis. The biological
process terms associated with direct perturbation targets were defined as ”target terms”.
Separately, the GO terms enriched among the candidate signalling molecules were collected,
as well as the terms enriched among non-candidate molecules. The presence of target terms
among the two sets of enriched terms was considered. Target terms were overrepresented
more frequently among the candidate signalling molecules than among the non-candidate
ones (one-sided Wilcoxon test, p-value<2.2e-16, Figure 4.9A). Thus, candidate molecules
were involved in the same biological processes as the direct perturbation targets more than
signalling molecules discarded by INCanTeSIMO.
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Figure 4.9: Functional and topological properties of candidate molecules. (A) Percentage of functional
terms mapping to the perturbation targets also enriched in the signalling molecules selected as
candidates by INCanTeSIMO, or the molecules not selected. The candidates have significant higher
portion of enriched functional terms shared with the perturbation targets. (B) The average distance of
the selected molecules and non-selected molecules from the direct perturbation targets show that
candidates predicted by INCanTeSIMO are located significantly closer to the true perturbation than
non predicted molecules.
To study where candidate signalling molecules were located in the signalling network, the
distance from each molecule in the network to the perturbation target was defined as the
minimum number of interactions with same direction required to connect two nodes. The
average distance of candidate molecules and non-candidate molecules from the perturbation
targets showed significant difference (one-sided Wilcoxon test, p-value<2.2e-16, Figure
4.9B). For the majority of the datasets, the distances were significantly shorter for candidate
molecules (74% of datasets), longer in 2% of the cases, and comparable in the remaining
24%. This result indicates that candidate molecules are not distributed randomly on the
signalling network, but are gathered in the region where the experimental perturbation exerts
its function.
In summary, the candidate molecules selected by the proposed method are involved in the
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same biological processes and pathways as perturbation targets more than non-candidate
molecules and DEGs. Their placing in the network is also not casual but shows similarity
to perturbation targets. These results suggest that perturbation of candidate signalling
molecules, even if not yet experimentally tested, are likely to induce the desired cellular
conversion in the same way that known perturbations do.
4.4 Performance in the prediction of signalling pathways for cel-
lular transitions
To better interpret the prediction of signalling molecules obtained with INCanTeSIMO, a
method for the prediction of canonical pathways, INCanTeSIMO path, was developed. Be-
cause candidates are selected by INCanTeSIMO based on their specific activity on the
interface TFs, it is expected that only some members of a pathway will be predicted, while
others acting with less specificity will not be prioritized. Therefore, over-representation of
the members of a pathway among the candidates is not necessary for a pathway to be
relevant to the desired cellular transition. Instead, the pathways were ranked according to
their enrichment in causal disturbance, calculated according to source/sink centrality (see
Methods section 3.2.1). Briefly, this method selects pathways based on the fact that highly
influential nodes in their signal transduction are predicted as candidates by INCanTeSIMO.
To evaluate the performance of INCanTeSIMO path, positive pathways were determined
for each dataset from the direct targets of the experimental perturbation. In particular,
MetaCore signalling pathways that contain at least 25% of the direct perturbation targets
were collected. Additionally, perturbation targets that only belong to one pathway were
selected, and such pathways were added to the positive ones (see Methods section 3.2.1).
The activation and inhibition of a pathway were considered separately. Finally, 166 datasets
among the 228 analysed had at least one positive MetaCore pathway, with a median of 3
positive pathways per dataset.
INCanTeSIMO path correctly predicted positive pathways in 58% of the cellular transitions
(p.value≤0.05), compared to an expected success rate of 47% for the random selection of
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the same number of pathways. The probability of selecting at least one positive pathway by
chance is affected by the number of positive pathways, therefore the datasets were classified
according to the number of positive pathways, and the probability of random success in each
class was compared to the performance obtained by INCanTeSIMO path (Figure 4.10). The
method was better than random selection for datasets with 2 to 4 positive pathways (p-values
3.7e-2, 5.4e-2, 5.2e-2), which represent 65% of all datasets, and comparable to random
selection in the other cases.
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Figure 4.10: Performance of INCanTeSIMO path in relation to the number of positive pathways.The
datasets were divided in classes according to the number of positive pathways present, and the
expected success rate was calculated for each dataset depending on the number of pathways and the
number of candidates selected by INCanTeSIMO path (light blue dots). The fraction of datasets in
each class where INCanTeSIMO predicted correctly at least one of the positive pathways is depicted
with short red bars. The overall success rate of INCanTeSIMO (red dotted line, 58%) and the overall
expected success rate (blue dotted line, 47%) are reported.
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4.5 Comparison to other methods
No method exists to date similar to this work in terms of application or modelling strategy. The
approach presented was therefore compared to computational tools that are widely used to
analyse signalling events using gene expression data. As mentioned in the Methods section
3.3, they are methods that predict both signalling molecules (Connectivity Map, DeMAND)
and entire pathways (SPIA, GSEA, CADIA).
4.5.1 Comparison to single molecule prediction tools
The performance obtained with INCanTeSIMO was compared to Connectivity Map and
DeMAND. These two methods use DEGs but otherwise follow quite different strategies for
the prediction of potential perturbations. Connectivity Map takes advantage of an extensive
database of gene expression signatures generated by known perturbations, and searches
for similarities with the query expression profile. DeMAND, on the other hand, calculates the
enrichment of deregulated genes among the targets of each potential perturbation, defined
by a context-specific regulatory network.
Connectivity Map was applied to all 228 datasets. Both INCanTeSIMO and Connectivity
Map had a success rate of 61% on the datasets associated with a prediction (Figure 4.11A),
however in some datasets there were not enough DEGs for Connectivity Map to give a
result, so predictions were available in 144 datasets only. The majority of the datasets
analysed are already present in the compendium of gene expression signatures used for
Connectivity Map for generating predictions. A closer look at the cell fate transition cases,
which were obtained from independent data sources, revealed that Connectivity Map correctly
predicted perturbations in only 25% of the cases, while INCanTeSIMO succeeded in 75%
of them (Figure 4.11B). Thus, Connectivity Map could not be successfully applied to novel
cellular transitions. INCanTeSIMO on the contrary showed consistent performance across
the different types of datasets.
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Figure 4.11: Performance of INCanTeSIMO compared to Connectivity Map. (A) Number and proportion
of datasets in which INCanTeSIMO and Connectivity Map correctly predict at least one of the known
perturbation targets. INCanTeSIMO generated predictions for all 228 datasets, while Connectivity Map
failed to analyse 84 datasets. (A) Number and proportion of cell fate transitions in which INCanTeSIMO
and Connectivity Map obtained correct predictions. These datasets are a subset of the 228 analysed
overall.
DeMAND (Woo et al. 2015), which is one of the few GRN-based tools available, could not
be compared with INCanTeSIMO in the same manner, because of its requirement for at least
six gene expression data replicates per condition. Therefore, INCanTeSIMO was applied to
eight datasets used for DeMAND’s benchmarking and compatible with our method. Across
these drug-induced cellular transitions, both INCanTeSIMO and DeMAND correctly predicted
perturbation targets in six datasets (Figure 4.12). The fact that INCanTeSIMO obtained a
comparable performance to a method which requires substantially more data, while also
indicating if the candidate molecules should be activated or inhibited (correct sign predicted
in 5/6 datasets), suggests that it is a flexible method suitable for a wide range of applications.
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Figure 4.12: Performance of INCanTeSIMO and DeMAND on the eight compound perturbation
datasets that could be analysed with both methods. Both tools predicted direct perturbation targets for
6 datasets and were not successful in predicting targets of (S)-equol and thapsigargin.
4.5.2 Comparison to pathway prediction tools
The performance of INCanTeSIMO path in predicting signalling pathways for the induction of
cellular transitions was compared to existing approaches that analyse differential pathway
activity by focusing on DEGs. There exist three main classes of methods: over-representation
analysis (ORA), functional class scoring (FCS), and topological analysis (Khatri, Sirota, and
Butte 2012). Here representative methods for each classes were selected: enrichment by
hypergeometric test (ORA), gene set enrichment analysis (GSEA) (FCS), and the methods
SPIA and CADIA, which combine ORA and topological measures (see Methods for a brief
description of each method). Causal network inference methods were not applied to this
analysis because they consider reduced sets of pathways or TFs (Catlett et al. 2013; Parikh
et al. 2010), or have limited applications, as in the case of cancer-specific methods (Y.-A.
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Kim, Wuchty, and Przytycka 2011; Paull et al. 2013) and tools assuming that the signalling
perturbation is known (Melas et al. 2015).
As mentioned in the Methods section 3.2.1, the “positive” pathways for each dataset were
determined from the direct perturbation targets. SPIA and CADIA by default predict KEGG
pathways, while all other methods can be adapted to predict MetaCore canonical pathways,
so both MetaCore and KEGG positive pathways were determined for each dataset. The
166 datasets that had both KEGG and MetaCore positive pathways were considered for
assessment of pathway analysis: each dataset was assigned up to 66 MetaCore positive
pathways (median 3), and up to 77 KEGG positive pathways (median 5).
The performance of each method was quantified as the number of datasets in which at
least one positive pathway was predicted as significant according to the method-specific
significance cut-off. However, not all methods generated predictions for each dataset, as
reported in Figure 4.13A. In fact, methods that use DEGs as input for the prediction failed to
predict pathways in a major portion of the datasets (from 41% for SPIA to 73% for CADIA).
This was due to the quantity of DEGs present in each dataset, which varied greatly but was
generally low (0 to 5855, median 96.5). In comparison, the number of candidate signalling
molecules generated by INCanTeSIMO was fairly high and stable (196 to 476 candidates in
each dataset, median 304.5), allowing the methods that used them as input data to calculate
pathway enrichments in all datasets. The only method that obtained correct predictions in
more than 50% of the datasets was INCanTeSIMO path (Figure 4.13A). However, this result
was dependent on the number of pathways predicted by each method, which was higher for
INCanTeSIMO path than all other methods (Figure 4.13B). To evaluate the goodness of the
ranking obtained with each method, the number of pathways that needed to be selected from
the ranking in order to pick positive pathways was calculated across all 166 datasets with all
the tested methods (Figure 4.14A).
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Figure 4.13: Overview of the results for pathway prediction methods. (A) Performance of the methods
for pathway prediction. A prediction is considered correct if at least one of the positive pathways is
predicted, and incorrect otherwise. Cases where there was no prediction are reported as missing.
The red dotted line represents 50% of all datasets (in total 166). (B) Number of pathways predicted by
each method, according to the significance level recommended in each method.
The results clearly showed that using the signalling candidates obtained from INCan-
TeSIMO resulted in a better ranking of canonical pathways. The selection of the best 19
pathways according to INCanTeSIMO path was sufficient to obtain correct predictions in half
of the datasets (”candidates SSC”), applying pathway enrichment to the candidate molecules
(”candidates enrichment”) required 25.5 pathways to obtain successful predictions in 50% of
the datasets, and applying CADIA on MetaCore pathways using the candidate molecules
(”candidates CADIA”) required 24 pathways for the same result. This performance was con-
sistently better than the methods based on DEGs (Figure 4.14A, the ranking were significantly
different according to Kolmogorov-Smirnov test, p.value<1e-13 for all DEG-based methods).
In fact, 60.5 pathways were required using SPIA, 140 in pathway enrichment, while for CADIA
and GSEA even considering all KEGG or MetaCore pathways respectively was not sufficient
to obtain correct predictions in 50% of the datasets.
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Figure 4.14: Overview of the results for pathway prediction methods. (A) Fraction of datasets where at
least one positive pathway is correctly predicted for each of the pathway prediction methods. Candidate
SSC corresponds to the ranking used in INCanTeSIMO path (source/sink centrality enrichment across
the candidate molecules obtained from INCanTeSIMO). Because some tools did not return any
prediction in some datasets, considering all ranked pathways does not allow to reach success rate
=1. (B) Correlation between the rankings obtained with the different methods using INCanTeSIMO
candidate molecules as input for the prediction of pathways. SSC corresponds to the approach
implemented in INCanTeSIMO path. The rankings obtained with enrichment or CADIA are highly
concordant, while SSC obtains rankings that are quite different from both.
Therefore, INCanTeSIMO path predicted more signalling pathways, but also ranked them
more correctly, thus obtaining a better performance compared to DEG-based methods. The
performance at increasing number of selected pathways of INCanTeSIMO path was compa-
rable with the one obtained by calculating pathway enrichment or CADIA enrichment using
the candidate molecules (Kolmogorov-Smirnov test, p.value=0.11 in both cases). However,
INCanTeSIMO path required slightly less pathways to be selected in order to obtain a suc-
cessful prediction in 50% of the datasets, and was therefore the best method among the
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tested. Additionally, the ranking of predicted pathways was different between INCanTeS-
IMO path and the other candidate-based methods, and similar between pathway enrichment
and CADIA (Figure 4.14B), proving that the similar performance of INCanTeSIMO path to the
other candidate-based methods was not generated by the similarity of the methods overall.
In fact, the definition of positive pathways based on the number of perturbation targets they
contain, gives an advantage to pathway enrichment methods, and particularly enrichment in
candidate molecules (assuming they are direct perturbation targets). The fact that INCan-
TeSIMO path performed better than these methods proved that source/sink centrality is an
effective alternative metric for the prediction of signalling pathways that can control the GRN
state.
In summary, the prediction of pathways inducing cellular transitions is a complex problem
in which no method could achieve high performance. Using the candidates obtained from
INCanTeSIMO resulted in better predictions compared to DEG-based methods, while also
suggesting the activation or inhibition of signalling pathways. INCanTeSIMO path is the only
method taking into account explicitly the importance of specific molecules in the context of
signal transduction in signalling pathways combined with the causal role of signalling on
GRNs, instead of an over-representation criterion. It showed the best success rate among all
methods and the best ranking overall, suggesting that the integrative approach followed is
the suitable for modelling the interplay between cell signalling and GRNs in the context of
cellular transitions.
4.6 Cell fate transition examples
The ability to induce the transition between different cell types opens the door to advances in
regenerative medicine, as it could be used to replace damaged tissues and organs, both ex
and in vivo. INCanTeSIMO was applied to datasets where single growth factors or chemical
compounds induced changes in cellular identity. Compared to other datasets, here the GRNs
associated to the cellular conversion were larger (on average 38 vs 23 GRN TFs), and the
method achieved a better performance. Direct targets of the experimental perturbation were
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found among the candidate signalling molecules in 75% of all datasets (Table 4.1).
4.6.1 Differentiation
Nine differentiation cases were considered. Human mesenchymal stromal cells differen-
tiate into chondrocyte when treated with either BMP2 or TGF-β3 (Mrugala et al. 2009).
INCanTeSIMO predicted the activation of BMP receptor 2 and TGFBR3 when applied to the
BMP2-treated gene expression data, and the activation and inhibition of other members of
the TGF-β protein superfamily, which plays a key role in chondrocyte differentiation, when
analysing TGF-β3-treated gene expression.
INCanTeSIMO also correctly predicted targets for the differentiation of hematopoietic
stem/progenitor cells to erythroid and megakaryocytic precursors (Zini et al. 2012), for
the terminal differentiation of neonatal keratinocytes (Q. T. Tran et al. 2012), and for the
induction of hepatoblasts differentiation towards hepatocyte-like cells (Ogawa et al. 2013).
The differentiation of myeloid-derived suppressor cells into M2-like macrophages (Wang et al.
2015) and of intestinal stem cells into secretive progenitor cells (T.-H. Kim et al. 2014) were
also correctly associated with experimentally perturbed signalling molecules.
4.6.2 Cell activation and maintenance
Among the cellular conversions considered there were cases of specification of a new cellular
fate. The activation of pre-adipocytes to primed adipocytes was correctly associated with
the activation of DAX1, a nuclear receptor for steroid hormones (Tomlinson et al. 2010).
The specification of mesenchymal stem cells towards the subendothelial murate cell fate is
activated by TGF-β1 treatment and impeded by bFGF (Sacchetti et al. 2007). In accordance
with these observations, our method predicted bFGF targets and regulators as involved in
both processes.
Table 4.1: Signalling molecules predicted in cell fate transitions
73
CHAPTER 4. RESULTS
Ty
pe
In
iti
al
 c
el
l t
yp
e
Pe
rtu
rb
at
io
n
Fi
na
l c
el
l t
yp
e
Re
f.
Be
st
 
ra
nk
Pr
ed
ic
te
d 
di
re
ct
 ta
rg
et
s
no
te
s
AL
K-
2
C
ho
rd
in
__
in
h
BM
P 
re
ce
pt
or
 2
N
og
gi
n_
_i
nh
Ec
to
di
n_
_i
nh
D
TG
F-
β3
38
En
do
gl
in
__
in
h
BM
P2
 ta
rg
et
s 
pr
ed
ic
te
d :
 C
ho
rd
in
 | 
N
og
gi
n 
| 
Ec
to
di
n 
| P
TC
H
1_
_i
nh
H
D
AC
9_
_i
nh
H
D
AC
2
Er
bB
4
M
SK
1
D
he
pa
to
bl
as
ts
cA
M
P
he
pa
to
cy
te
-li
ke
 c
el
ls
(O
ga
w
a 
et
 a
l. 
20
13
)
14
3
Pr
ot
ei
n 
ki
na
se
 G
1
R
84
8
 tu
m
or
ic
id
al
 M
1-
lik
e 
m
ac
ro
ph
ag
es
-
TL
R
7_
_i
nh
 | 
TL
R
8_
_i
nh
 (o
pp
os
ite
 s
ig
n)
PA
M
3
im
m
un
os
up
pr
es
si
ve
 M
2-
lik
e 
m
ac
ro
ph
ag
e
78
TL
R
1
At
oh
1 
in
hi
bi
tio
n
en
te
ro
cy
te
 p
ro
ge
ni
to
rs
-
di
be
nz
az
ep
in
e
se
cr
et
iv
e 
pr
og
en
ito
rs
56
N
O
TC
H
1 
(N
IC
D
)_
_i
nh
D
D
er
m
om
yo
to
m
e
C
H
IR
99
02
1
m
yo
to
m
e
(N
ak
aj
im
a 
et
 
al
. 2
01
8)
-
A
pr
e-
ad
ip
oc
yt
es
de
xa
m
et
ha
so
ne
pr
im
ed
 p
re
-a
di
po
cy
te
s
(T
om
lin
so
n 
et
 
al
. 2
01
0)
93
D
AX
1
C
as
ei
n 
ki
na
se
 II
, a
lp
ha
 c
ha
in
s
C
as
ei
n 
ki
na
se
 II
, a
lp
ha
' c
ha
in
 
(C
SN
K2
A2
)
A
TG
F-
β1
su
be
nd
ot
he
lia
l m
ur
al
 c
el
l f
at
e
10
3
U
bi
qu
iti
n
bF
G
F 
ta
rg
et
s 
pr
ed
ic
te
d:
 S
yn
de
ca
n-
3_
_i
nh
 | 
C
as
ei
n 
ki
na
se
 II
, a
lp
ha
' c
ha
in
 (C
SN
K2
A2
)_
_i
nh
 
| S
10
0B
__
in
h
M
-
86
AL
K-
4
Pr
ot
oc
ol
s 
co
m
pa
ris
on
: M
EF
 fe
ed
er
AL
K-
4
AL
K-
7
AL
K-
2_
_i
nh
R
M
EF
s 
(M
ou
se
 E
m
br
yo
ni
c 
Fi
br
ob
la
st
s)
SB
-4
31
54
2
As
tro
cy
te
s
(T
ia
n 
et
 a
l. 
20
16
)
41
TG
F-
be
ta
 1
__
in
h
R
M
ou
se
 e
m
br
yo
ni
c 
fib
ro
bl
as
ts
C
H
IR
99
02
1 
+ 
R
ep
So
x 
+ 
Fo
rs
ko
lin
 +
 v
al
pr
oi
c 
ac
id
ca
rd
io
m
yo
cy
te
s
(F
u 
et
 a
l. 
20
15
)
16
6
R
ep
So
x:
 J
N
K1
(M
AP
K8
)_
_i
nh
89
SP
60
01
25
 : 
p3
8b
et
a 
(M
AP
K1
1)
__
in
h;
 
JA
K3
__
in
h;
 M
SK
1_
_i
nh
G
o6
98
3:
 cP
KC
 (c
on
ve
nt
io
na
l) 
(o
pp
os
ite
 s
ig
n)
SB
20
21
90
: p
38
be
ta
 (M
AP
K1
1)
__
in
h;
 
p3
8a
lp
ha
 (M
AP
K1
4)
__
in
h
(W
an
g 
et
 a
l. 
20
15
)
(K
im
 e
t a
l. 
20
14
)
R
Ad
ul
t f
ib
ro
bl
as
ts
SP
60
01
25
 +
 S
B2
02
19
0 
+ 
G
o6
98
3
hM
SC
(L
ai
 e
t a
l. 
20
17
)
Pr
ot
oc
ol
s 
co
m
pa
ris
on
: f
ee
de
r-f
re
e
15 15
-
M
(T
sa
i e
t a
l. 
20
10
)
ac
tiv
in
 A
 +
 b
FG
F
hE
S-
T3
24
no
n-
H
M
E 
ce
lls
bF
G
F
A
Er
yt
hr
oi
d 
an
d 
m
eg
ak
ar
yo
cy
tic
 
pr
ec
ur
so
rs
va
lp
ro
ic
 a
ci
d
H
SP
C
D
(T
ra
n 
et
 a
l. 
20
12
)
te
rm
in
al
ly
 d
iff
er
en
tia
te
d 
ke
ra
tin
oc
yt
es
de
ns
ity
-in
du
ce
d 
di
ffe
re
nt
ia
tio
n,
 tr
ea
te
d 
w
ith
 
N
H
EK
D
(S
ac
ch
et
ti 
et
 
al
. 2
00
7)
m
es
en
ch
ym
al
 s
te
m
 c
el
ls
TG
F-
β3
 ta
rg
et
s 
pr
ed
ic
te
d:
 T
G
F-
be
ta
 re
ce
pt
or
 
ty
pe
 II
I (
be
ta
gl
yc
an
)
(M
ru
ga
la
 e
t a
l. 
20
09
)
ch
on
dr
oc
yt
es
hM
SC
(Z
in
i e
t a
l. 
20
12
)
BM
P2
D D
m
M
D
SC
 (M
ye
lo
id
-d
er
iv
ed
 
su
pp
re
ss
or
 c
el
ls
)
In
te
st
in
al
 s
te
m
 c
el
ls
 (I
SC
)
10
D
74
CHAPTER 4. RESULTS
Maintenance of cell identity sometime also requires supplementing the culture medium
with growth factors or compounds. Maintenance of hESC-T3 is achieved with standardized
protocols (MEF feeder or feeder-free) or in conditioned medium with the addition of activin A
(Tsai et al. 2010). Comparing the latter with established protocols, INCanTeSIMO correctly
predicted the activation and inhibition of multiple activin receptors.
4.6.3 Transdifferentiation
The transdifferentiation of mouse embryonic fibroblasts into astrocytes is obtained experimen-
tally with SB-431542 (Tian et al. 2016), an inhibitor of the TGF- β type I receptor kinase activity
(Laping 2002). Correctly, it was predicted that the inhibition of TGF-β1 would induce this
cellular transition. Additionally, INCanTeSIMO was tested on two cases of transdifferentiation
that were obtained with the combination of multiple chemical compounds.
The direct conversion of mouse embryonic fibroblasts to cardiomyocytes can be induced
with the minimal combination of four distinct compounds (CHIR99021, RepSox, Forskolin, and
valproic acid). INCanTeSIMO only predicted a direct target of RepSox, but further inspection
into the candidate signalling molecules revealed the activation of Axin, which is a target of
both GSK3, which is inhibited by CHIR99021, and of G-protein alpha-s, a target of Forskolin.
On the other hand, no direct or indirect target of valproic acid were among the candidates.
Human dermal fibroblasts are converted in mesenchymal stem cells with the minimal
combination of SP600125, SB202190 and Go6983 (Lai et al. 2017). In this context, INCan-
TeSIMO correctly predicted three targets of SP600125 (the inhibition of p38, JAK3 and MSK1)
and two SB202190 targets (the inhibition of p38 in its α and β forms). Regarding Go6983,
our method predicted the activation, instead of the inhibition, of protein kinases C.
In summary, signalling molecule perturbations inducing cell fate conversions were con-
sistently captured by INCanTeSIMO. Notably, the method was able to predict alternative
perturbations for the same conversion, as in the case of mesenchymal stromal cells dif-
ferentiated into chondrocytes, and mutually exclusive perturbations, with the prediction of
activation or inhibition of bFGF signalling molecules to induce or inhibit the specification
of subendothelial murate cell fate in mesenchymal cells. This suggests that among the
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predicted candidates are recapitulated both experimentally known perturbations, but also
other biologically relevant ways of inducing the same cellular conversion.
4.6.4 Pathway-level predictions
As mentioned previously, in order to assess the performance of INCanTeSIMO path the
positive pathways for each dataset were determined from the direct perturbation targets,
and the method could correctly predict them in 58% of the datasets. In order to confirm the
overall good quality of the predictions, literature evidence was collected that could clarify if
pathways that are not related to the experimentally applied perturbation, but are predicted by
INCanTeSIMO path, could induce the cellular transitions studied. In general, the pathways
predicted were previously implicated in the cellular conversion analysed, as shown in Table
4.2. A few examples are discussed here:
• While not containing targets of the experimental perturbation, the inhibition of NOTCH
signalling pathway was reported previously to improve the differentiation of hMSCs
to chondrocytes (Sun et al. 2018). Other correct predictions for this transition include
the activation of ossification (Su et al. 2018), response to hypoxia (Kanichai et al.
2008; Koay and Athanasiou 2008) and androgen receptor (S.-s. C. Huang et al. 2013)
pathways.
• The differentiation of dermomyotome into myotome has been previously associated
with the activation of insulin (Pirskanen, Kiefer, and Hauschka 2000) and inhibition of
BMP signalling (Reshef, Maroto, and A. B. Lassar 1998), which contain the targets
for the perturbation experimentally tested (CHIR99021). Among our predictions, also
ERK5 signalling (Carter et al. 2009; Delfini et al. 2009) and the inhibition of TGF-β
signals (J. Zhou and Sears 2018) have were supported by literature evidence.
Table 4.2: Top pathways predicted by INCanTeSIMO path for cell fate transitions
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Type Transition Perturbation Bool # pathways predicted Predicted pathway Sign Rank
Contains 
perturbation 
targets
Literature
IL-2 + 1 no
T cell receptor + 2 no
MIF - 3 no 10.1016/j.stemcr.2016.07.003
ossification + 18 yes 10.3390/ijms19082343
response to hypoxia + 1 no [1] 10.1016/j.joca.2008.04.007; [2]  10.1002/jcp.21446
synaptogenesis + 2 no
NOTCH - 3 no 10.1038/s12276-018-0151-9
Androgen receptor cross-talk + 13 yes 10.1016/j.scr.2013.06.001
ERK5 + 1 no [1] 10.1016/j.ydbio.2009.05.544; [2] 10.1242/jcs.045757
neurogenesis - 2 no
antigen presentation + 3.5 no
TGFb - 3.5 no 10.1002/dvdy.24681
insulin + 5 yes 10.1006/dbio.2000.9784 
BMP in cardiac development - 14 yes 10.1101/gad.12.3.290
Innate inflammatory response - 1 no
IL-10 + 2.5 no 10.1189/jlb.3A0414-210R
JAK/STAT + 2.5 no 10.3389/fimmu.2018.00608
response to RNA viral infection - 4 no
Th cell differentiation + 10 yes 10.3389/fimmu.2019.00219
Skeletal muscle development + 1 no
Wnt + 2 no 10.1073/pnas.0509703103
TGFb + 3 no 10.18632/oncotarget.10561
Phagosome in antigen presentation - 1 no 10.1155/2017/7970385
phagocytosis - 2 no
death receptors + 3.5 no
response to RNA viral infection - 3.5 no
EMT + 9 yes 10.15252/embj.201591517
Phagosome in antigen presentation - 1 no 10.1155/2017/7970385
Neutrophil activation - 2 no
phagocytosis - 3.5 no 10.1007/s00427-012-0422-8
D hMSC -> chondrocytes TGF-beta 3 frmaBool 15
D hMSC -> chondrocytes BMP2 frmaBool 19
D
mMDSC (Myeloid-derived 
suppressor cells)-> 
tumoricidal M1-like 
macrophages
R848 geneDE 19
D dermomyotome -> myotome CHIR99021 geneDE 18
D Intestinal stem cells (ISC) -> enterocyte progenitors Atoh1 inhibition geneDE 19
D
mMDSC-
>immunosuppressive M2-
like macrophage
PAM3 geneDE 10
D ISC -> secretive progenitors dibenzazepine geneDE 9
amphoterin + 3.5 no
death receptors + 2.5 no 10.1002/jcp.25967
neurogenesis - 2.5 no
NK cell cytotoxicity - 2.5 no
T cell receptor - 1 no
protein C + 2 no 10.4331/wjbc.v5.i2.169
NK cell cytotoxicity - 3 no 14760888
ossification - 1 no
MIF + 2 no
antigen presentation + 3 no
insulin - 1 no
IFN-gamma + 2 no 10.3389/fimmu.2015.00539
antigen presentation + 3 no 10.1016/j.stemcr.2018.09.015
angiogenesis - 15 yes 10.1074/jbc.M109.006551
MIF + 2 no
Phagosome in antigen presentation - 2 no 10.1002/stem.406
amphoterin + 2 no
neuropeptides - 3 no
NOTCH - 3 no
Neuromuscular junction - 3 no
B cell receptor - 3 no
IL-2 + 3 no
ossification - 2 no 10.1038/cdd.2015.168
response to RNA viral infection + 2 no 10.1210/en.2009-1140
neurogenesis + 2 no
MIF - 10 yes 10.1038/emm.2015.26
Neutrophil activation + 15 yes
Th cell differentiation - 16 yes 10.4049/jimmunol.1001269
Neutrophil activation - 18 yes
D HSPC -> erythroid and megakaryocytic precursors valproic acid frmaBool 24
   
D hepatoblasts -> hepatocyte-like cells cAMP frmaBool 19
D NHEK -> terminally differentiated keratinocytes
density-induced 
differentation + 
EGF
frmaBool 11
A MSC -> non-HME cells bFGF frmaBool 38
T MEFs (Mouse Embryonic Fibroblasts)->Astrocytes SB-431542 geneDE 23
A pre-adipocytes -> primed pre-adipocytes dexamethasone frmaBool 28
A MSC -> subendothelial mural cell fate TGFb frmaBool 35
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• Myeloid derived suppressors cells (MDSCs) can differentiate towards M1- or M2-
like macrophages. INCanTeSIMO path correctly predicted that IL-10 and JAK/STAT
signalling are involved in M1 differentiation (Bayik, Tross, and Klinman 2018; Beury et al.
2014) and it associated TGF-β and Wnt pathways to M2-like differentiation (Pukrop
et al. 2006; F. Zhang, R. Liu, and J. Zheng 2016).
Overall, many of the pathways predicted, though not associated with the experimental
perturbations, could be involved in the cellular transitions studied. These results show that
INCanTeSIMO path is able to predict pathways involved in cellular transitions independently
of how the transition was induced in the experiments that generated the gene expression
data used for the prediction.
4.7 Applications to animal models of disease and regeneration
The methods presented here were applied to the prediction of signalling molecules and
pathways involved in the transition from a pathological to a healthy state in a rat model of
cirrhosis, obtained with the treatment with CCl4. Secondly, the molecules and pathways
involved in the regeneration of amputated salamander limbs were identified by applying the
present methods to time series gene expression data.
4.7.1 Reversion of cirrhotic state in rat liver
Currently liver transplantation is the only effective therapy available for cirrhotic patients,
and new therapeutic strategies are urgently needed, also in the prospect of avoiding further
advancing of the disease towards hepatocellular carcinoma (HCC). Wistar rats treated with
CCl4 represent a classical disease model for cirrhosis. Gene expression data from cirrhotic
and healthy rat liver was used to predict which signalling perturbations could induce the shift
between diseased and healthy tissue state (Figure 4.7.1A).
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RXRA 1 0 0 0 1
TP63 1 0 0 1 0
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Probability
c−Rel (NF−kB subunit)
ESR1 (nuclear)
ETS1
GCR
PU.1
SP1
STAT3
STAT5A
STAT5B
TCF8
C
80
CHAPTER 4. RESULTS
Figure 4.15: Prediction of signalling perturbations for the reversal of the cirrhotic phenotype in rat liver.
A) Overview of the approach followed: liver gene expression data of cirrhotic rats were generated
by collaborators, and used as the initial cellular state. Gene expression data for the desired healthy
state was obtained from GEO. Once the activation of Tie2 was predicted by INCanTeSIMO, cirrhotic
rats were treated with its agonist CVX-060, gene expression data was generated from treated liver
and compared with the healthy state. B) The state of the TFs in the GRN in the cirrhotic, healthy and
CVX-060 treated samples. The ideal perturbation state refers to the state that the GRN TFs can reach
if any of the BPCs is applied. The predicted CVX-060 treated state is the state the GRN-TFs can
have if the BPCs composed only of interface TF states induced by the activation of Tie2, according to
INCanTeSIMO (using correlation-based MPPs). Green background shows when a state is matching
the desired healthy state. C) Interface TFs present in the BPCs and their relative probability of inducing
the desired changes on the GRN. +: the activation of the interface TFs has desired effect on the GRN;
–: its inhibition is effective. The two states are not mutually exclusive, as seen in c-Rel (NF-kB subunit).
Gene expression of whole cirrhotic livers was quantified with microarray experiments,
and compared with healthy liver data obtained from public databases (see Materials and
Methods section 3.4). The GRN model representing the cellular transition between cirrhotic
and healthy state (disease GRN) consisted of 26 TFs (Figure 4.7.1B), and 106 interface
TFs were available for perturbation. After exhaustive in silico perturbation, the BPCs were
predicted to affect the state of 19 GRN-TFs (Figure 4.7.1B), and were composed of 10
interface TFs (Figure 4.7.1C).
Signalling molecules were ranked using INCanTeSIMO. Among the candidate molecules
many proteins are known to be involved in different aspects of cirrhosis, or other liver diseases
such as fibrosis, fatty liver disease and HCC. As mentioned in the Introduction (1.4.1), fibrosis,
inflammation and blood vessel structure are fundamental biological processes involved in the
development of liver cirrhosis.
Among the predictions obtained, there was the inhibition of proteins associated with
fibrosis (e.g. CHIP, AP-1, CBP, MDM2) and matrix metallopeptidases responsible for matrix
remodelling, and the activation of ESR2 which is known for its antifibrogenic role (B. Zhang
et al. 2018). Additionally, multiple innate immune response proteins, including interleukins,
were correctly predicted (W.-C. Zhou 2014). Among the canonical pathways, BMP signalling
was predicted as inhibited by INCanTeSIMO path. Different BMP proteins act differently on
hepatic stellate cells (HSCs), BMP2 and BMP4 in particular potentiate their transdifferentiation
and have a profibrogenic effect (Herrera, Addante, and Sa´nchez 2017).
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Nitric oxide and NADPH signalling are also predicted as inhibited, in accordance to the
role of oxidative stress in HSC activation and proliferation (Adachi et al. 2005; Iwakiri and
M. Y. Kim 2015)(Table 4.3).
Members of angiopoietins signalling, which is a key pathway in blood vessel normalization,
are also present among the predictions. Signalling through Angiopoietin 1 (Ang1)-Tie2 is
known to stabilize blood vessels, while Angiopoietin 2 (Ang2) acts as a context-dependent
antagonist of Ang1, decreasing its effect and giving rise to immature blood vessels (Fagiani
and Christofori 2013). Higher expression and activity of Ang2 has been associated with
cirrhotic conditions. In agreement with this characteristics, INCanTeSIMO predicted the
activation of Angiopoiein 1 and 4, the inhibition of Angiopoietin 2 and 3, and the activation of
Tie2 (ranking 24th among all signalling molecules) (Table in Appendix 7.4).
The activation of Tie2 is predicted to induce activation of interface TFs SP1 and ETS1,
and the inhibition of GCR, STAT5A and B, ESR1, and PU.1 (Figure 4.16), resulting in a
GRN state that matches partially the healthy liver state (Figure 4.7.1B). This prediction was
validated by treating cirrhotic rats with CVX-060, a specific inhibitor of Ang2 which improves
Tie2 activity, and generating gene expression data for the whole liver. The GRN-TFs EBF1,
EGR3, PRDM1, RARG, RUNX3, SP7, and TP63 were observed to change their expression
state to match the healthy counterpart (Figure 4.7.1B). Literature evidence confirmed that
many of these TFs are indeed involved in liver cirrhosis and blood vessel stabilization.
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GRHL1
REST
FGF2 PRDM1 NR0B1 NEUROG1
MYBL2
ANKRD1
GREB1RELBSP7EGR3 HOXA1 MYOGSOX2FOSL1POU2F2
VDR SALL4TP63 RARGEBF1 FOSL2 PBX1RUNX3 RXRA
Casein kinase II, beta chain 
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ZAP70
p38alpha (MAPK14)
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SHP-1
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STAT5BSTAT5A ESR1 (nuclear)
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Specific to the disease to healthy GRN
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Figure 4.16: Integrated signalling and gene regulatory network for cirrhosis. The application of
CVX-060 specifically activates Tie2, which in turn activates (blue circles) or inhibits (red circles)
interface TFs following the MPPs depicted. The interface TFs act on the disease-vs-healthy GRN
(disease GRN). In the GRN, white TFs are common between this GRN and the treated-to-healthy
GRN (treatment GRN), and yellow TFs are specific for the disease GRN. Association of the TFs with
the regulation of angiogenesis is represented with a green border.
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EGR3 is a pro-inflammatory factor that can stimulate fibrosis when overexpressed, and
whose suppression has been shown to attenuate TGF-β signalling and consequently fibroge-
nesis (Fang et al. 2013). It also plays an essential role in VEGF signalling in angiogenesis
(D. Liu, D. Ghosh, and Lin 2008). Runx3 is expressed in embryonic liver and regulates fetal
hematopoiesis (Bruijn and Dzierzak 2017). Its inhibitions causes organogenesis defects in
mice, and excessive intrahepatic angiogenesis (J.-M. Lee et al. 2013). SP7 and TP63 have
been implicated in VEG-mediated angiogenesis (Farhang Ghahremani, Goossens, and Haigh
2013; W. Tang et al. 2012). Retinoic acid signalling through RARG was shown to reverse
hepatic stellate cell activation and fibrosis (Panebianco et al. 2017). PRDM1 and EBF1 do
not have a reported function in angiogenesis or cirrhosis to date, but have been connected
to other liver diseases: PRDM1 expression has recently been implicated with HCC (N. Li
et al. 2019), and EBF1 was observed to be differentially methylated in nonalcoholic fatty liver
disease cirrhosis (Gerhard et al. 2018). They could therefore represent novel therapeutic
targets.
To further consolidate the results obtained, a second GRN representing the transition
between the treated and healthy states was built (treatment GRN). It contained 30 GRN
TFs, of which 14 in common with the disease-to-healthy GRN (disease GRN). The 12 TFs
unique to the disease GRN were localized in network-specific modules, that contained
TFs implicated in vascular growth, including EGR3, RUNX3, SP7 and TP63 discussed
above (Figure 4.16). Modules that were shared between the two GRNs did not contain TFs
associated to angiogenesis, confirming that by activating Tie2 the expression state of TFs
regulating angiogenic processes was reverted to its healthy counterpart.
A previous functional study showed that inhibition of Ang2 and activation of Tie2 signalling
through CVX-060 treatment are beneficial to the stability of intrahepatic blood vessels and
cause a reduction of liver inflammatory infiltrate, overall improving the fibrotic condition in
cirrhotic rats (Pauta et al. 2015). The current analysis complements these previous results by
providing insights in the gene expression changes occurring during the treatment.
Still, activation of Tie2 does not completely revert the disease phenotype, suggesting that
multiple facets of the disease should be targeted together to induce a complete return to
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healthy expression profile and cellular state. For this, a combination of different candidate
molecules might be considered. For example, inhibition of endothelin ranks 17th among the
predictions (Table in Appendix 7.4). Endothelin-1 overexpression has been associated with
the pathological activation of HSCs, which are one of the main cells responsible for collagen
expression in the liver, and is also connected to exacerbated vasoconstriction leading to
intrahepatic vascular dysfunction (Tsuchida and Scott L. Friedman 2017).
4.7.2 Salamander limb regeneration
The approach developed here was applied to the prediction of signalling molecules and
pathways that drive the regeneration process in salamander limbs. In particular, the anal-
ysis considered the initial stages of the regeneration up to 14 days post amputation (dpa),
comprising the response to amputation, formation of the wound epithelium and subsequently
of the blastema. Gene expression data of cells from the mesenchymal lineage, expressing
Prrx1, was collected at amputation, 1, 3, 5, 7, 10, and 14 dpa.
A regeneration-specific GRN was built around the TFs that change their state between
any two consecutive time points during the time course, and then interval-specific GRNs
were extracted from it. GO enrichment showed that in each GRN there were TFs implicated
in the regulation of processes related to signalling, cellular differentiation and embryonic
development in agreement with expectations (Table in Appendix 7.5). For each of these
intervals, the signalling molecules able to induce the GRN to change from its initial to the final
state were predicted (see Methods section 3.5). The analysis of the interval between day 3
and day 5 did not identify interface TFs perturbations able to change the state of the GRN
substantially (>40% of the GRN-TFs) and this interval was therefore discarded.
Overall, the predictions revealed signalling molecules and pathways related to wound
healing up to 3 dpa, followed by cellular migration and de-differentiation around 5-7 dpa, and
finally cellular proliferation and re-differentiation (Table 4.4).
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Table 4.4: Selected signalling molecules and pathways predicted for the different stages of salamander
limb regeneration.
Signalling entity Time inter-
vals
Role Literature evidence
NADPH and ROS sig-
nalling (both signs)
0-1d Cellular activation and proliferation (Al Haj Baddar, Chithrala, and Voss
2019)
HDAC2 inhibition 0-1d Wound healing (Taylor and Beck 2012)
Phagocytosis 0-1d, 10-
14d
Wound healing (James W Godwin, Pinto, and N. A.
Rosenthal 2013)
HHs, Smoothened 0-1d, 7-14d Cellular proliferation and migration (B. Singh et al. 2015; B. N. Singh et al.
2012)
Wnt pathway 0-3d Wound healing (D. Zhang et al. 2009)
p38/JNK 0-3d, 7-14d Wound healing, EMT (Sader et al. 2019)
Bcl-2 0-3d,10-14d apoptosis (Bucan et al. 2018)
FGF receptors 0-10d Fibroblasts de-differentiation,
blastema formation
(Makanae, Mitogawa, and Satoh
2014)
ERK/MEK 0-14d blastema formation, blastema differ-
entiation
(Owlarn et al. 2017; Suzuki et al.
2007; Tasaki et al. 2011; Maximina H
Yun, Phillip B Gates, and Jeremy P
Brockes 2014)
PI3K/AKT 0-14d blastema formation (Suzuki et al. 2007)
GDF5 0-1d, 7-14d Blastema formation (Makanae, Hirata, et al. 2013)
Retinoic acid receptors 1-3d, 5-7d Apical epidermal cap, skeletal pattern-
ing and differentiation
(J. R. Monaghan et al. 2012; Nguyen
et al. 2017)
C/EBPβ 1-3d, 7-10d macrophage functionality (James W Godwin, Pinto, and N. A.
Rosenthal 2013; Ruffell et al. 2009)
Neuregulin 1 1-3d Blastema formation (Farkas, Freitas, et al. 2016)
p53 inhibition 1-7d Blastema formation (M. H. Yun, P. B. Gates, and J. P.
Brockes 2013)
ErbB2-3 5-7d, 10-
14d
cellular migration (Rojas-Mun˜oz et al. 2009)
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Table 4.4: Selected signalling molecules and pathways predicted for the different stages of salamander
limb regeneration.
Signalling entity Time inter-
vals
Role Literature evidence
Thrombin 5-7d Cell cycle re-entry (Imokawa and Jeremy P Brockes
2003; Maximina H Yun, Phillip B
Gates, and Jeremy P Brockes 2014)
FGF8 5-7d Cellular proliferation (Eugeniu Nacu et al. 2016)
MMPs 7-10d Blastema induction (Satoh, Makanae, et al. 2011)
BMPR1B 7-10d Chondrocyte differentiation (Kotzsch et al. 2009)
TNF-α 10-14d Blastema induction (Nguyen-Chi et al. 2017)
p53 7-14d Blastema differentiation (M. H. Yun, P. B. Gates, and J. P.
Brockes 2013)
In the initial time point (0 to 1 dpa), the predicted candidates include signals that have
been specifically associated with the initial steps of regeneration: p38/JNK signalling, which
has a central role in wound closure and EMT (Sader et al. 2019), ERK/MEK and PI3K/AKT
signalling, which are involved in the initiation of regeneration and blastema formation in X.
laevis and planarians (Owlarn et al. 2017; Suzuki et al. 2007; Tasaki et al. 2011). Bcl-2 is
among the predictions, in agreement with the reported importance of Bcl-2 family proteins
in the regulation of apoptosis in the initial phases of limb regeneration (Bucan et al. 2018).
The activation of Wnt signalling, which is generally associated with enhanced would healing
(D. Zhang et al. 2009), was also predicted.
Between 1 and 3 dpa, INCanTeSIMO predicted the activation of C/EBPβ, which has been
shown to play a fundamental role in regeneration by regulating macrophage functionality
(James W Godwin, Pinto, and N. A. Rosenthal 2013; Ruffell et al. 2009). The predicted
inhibition of NK cell cytotoxicity and T cell receptor signalling agree with the hypothesis that
inhibiting the lysis of progenitor populations might be necessary for successful regeneration
in salamander (James W. Godwin and N. Rosenthal 2014).
Following 5 dpa, the activation of ErbB proteins and Src/FAK signalling is predicted, in
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accordance with their role in cellular migration during vertebrate regeneration (Makanae
and Satoh 2012; Rojas-Mun˜oz et al. 2009). Additionally, the predicted activation of the
kallikrein-kinin signalling pathway, which includes coagulation factors and thrombin, is cor-
rectly associated to the initiation of the regenerative process (Imokawa and Jeremy P Brockes
2003).
At the next time step, between 7 and 10 dpa, there is the prediction of multiple matrix
metalloproteinases (MMP-2, 9, 13, 14). Importantly, they have been implicated with blastema
induction and regulation of Prrx1 expression in A. mexicanum (Satoh, Makanae, et al. 2011).
Multiple proteins belonging to the hedgehog pathway (Hedgehog, Smoothened, PKA, GLI3)
are predicted at this stage, in concordance with the observation that HH signalling is not
necessary for the dedifferentiation of mature cells, but is required for their proliferation and
migration (B. Singh et al. 2015; B. N. Singh et al. 2012). Insulin signalling has also been
associated with this stage (Stocum and Cameron 2011).
In the limb bud stage (10 to 14 dpa), TNF-α and the downstream NF-κB signalling are
predicted. TNF-α has been previously shown to play a primary role in the activation of
blastema cells in zebrafish (Nguyen-Chi et al. 2017). ERK signalling is predicted also at this
stage, in accordance with its activity in inducing blastema cells differentiation observed in
planarians (Tasaki et al. 2011).
Limb regeneration is a process that strongly depends on combination of signalling inputs
received by the blastema cells. Previous studies indicate that there is no single signal
responsible for the establishment of the regenerative program, but is the right combination of
different factors that leads to such biologic process. The guidance role is mainly associated
with dermis and peripheral nerves (Endo, Bryant, and David M. Gardiner 2004; Satoh, David
M. Gardiner, et al. 2007).
Dermis The apical epithelial cap (AEC), the most distal region of the wound epidermis, was
shown to regulate the blastema growth by expressing several growth factors that stimulate
cellular migration, proliferation, and changes in gene expression profiles. Among these factors
are the retinoic acid and fibroblasts growth factors (FGFs) and Wnt signalling molecules.
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FGFs are known to have a role in dedifferentiation of fibroblasts and in blastema formation,
but they are not sufficient to induce limb patterning (Makanae, Mitogawa, and Satoh 2014).
BMP2, BMP7 and growth and differentiation factor 5 (GDF5) work in coordination with FGFs
to induce the formation of blastema-like structures, by attracting fibroblasts to the wound site
(Makanae, Hirata, et al. 2013; Makanae, Mitogawa, and Satoh 2014). Retinoic acid, on the
other hand, plays a multifunctional role both in AEC (J. R. Monaghan et al. 2012) and in limb
patterning (Catherine D McCusker and David M Gardiner 2014). Wnt signalling is involved
in wound healing and positional information in the regenerating limb (S. Ghosh et al. 2008;
D. Zhang et al. 2009).
Nerves While the development of embryonic limbs is nerve-independent, regeneration in
adult salamanders depends on the innervation of the amputated limb. Limb denervation limits
blastema cells proliferation, an effect mediated by the interaction of the wound epithelium with
the regenerating nerve. The presence of nerves is necessary for scar-free wound healing, but
a higher nerve signalling is necessary (and sufficient) for blastema formation (C. McCusker,
Bryant, and David M. Gardiner 2015). Regenerating axons are thought to produce factors that
play a key role in cell proliferation. A number of factors have been identified that are present
in blastema cells, can rescue the regeneration in denervated limbs, and whose inhibition
hinders regeneration. They are anterior gradient protein (AG) (Kumar and Jeremy P. Brockes
2012), BMP2, BMP7, FGF2 and FGF8 (Makanae, Mitogawa, and Satoh 2014), Neuregulin 1
(Farkas, Freitas, et al. 2016), and transferrin (Mescher et al. 1997). Combinations of these
factors have been shown to effectively substitute the effect of innervation on the regenerative
process. Treatment of skin wounds with BMP7, FGF2 and FGF8 induces blastema formation
(Makanae, Mitogawa, and Satoh 2014), and the addition of FGF2, FGF8, and BMP2, followed
by RA treatment, is able to mimic the signalling cues brought to limb wounds by nerve
and positional identity, inducing the regeneration of complete limbs (Vieira and Catherine D.
McCusker 2019).
With the exception of AG protein and transferrin, not present in the signalling network
considered, these factors associated with both dermis and nerves signalling were consistently
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recovered during the analysis: Wnt and retinoic acid signalling were selected at initial time
points, Neuregulin 1 was identified between day 1 and 3, while FGF and BMP signals were
predicted for later stages.
Multiple other predictions could be confirmed by literature review. Both the activation
and inhibition of the NADPH and ROS signalling pathway were selected at 0 to 1 dpa,
supporting the idea that ROS are necessary for inducing regeneration, but at the same time
some counteracting processes might be in action in order to protect the progenitor cells
from excessive cellular stress (Miller, Johnson, and Whited 2019). Finally, as with immune
response, phagocytosis was predicted as activated initially, then inhibited at 5-7 dpa, and
activated again after day 10. Together with he activation of C/EBPβ at two different time
points, these results suggest that immune response mechanisms might play multiple roles
along the regenerative process.
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Figure 4.17: Signalling pathways predicted by INCanTeSIMO for each time interval along the regener-
ative process. Complete pathway names are in the Appendix 7.1.
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In summary, INCanTeSIMO and INCanTeSIMO path predictions could identify known
pathways and proteins involved in the initial stages of salamander limb regeneration. Regard-
ing signalling pathways, canonical pathways involved in signal transduction were predicted
all along the regeneration process, and multiple pathways involved in development were
predicted starting from the fifth day post amputation 4.17. In some cases, candidate proteins
had been associated with regeneration in other animal models such as newts, zebrafish or
planarians. For other proteins, it was observed that changes in their gene expression or
protein abundance occur at specific regeneration stages, but their functional role has to be
determined yet. These proteins constitute novel candidates for experimental validation in A.
mexicanum. As it is well established that some of the signals involved in the regenerative
process are not secreted by the analysed blastema cells (Prrx1+), an additional refinement
of the candidates for experimental validation could consist in identifying the molecules ex-
pressed by specific surrounding cell types, such as macrophages, neurons or epidermal cells
of the AEC.
93
5 Discussion and perspectives
Signalling pathways exert their functions by transmitting stimuli and inducing cellular re-
sponses to them. In particular, cell signalling can regulate the cellular gene expression
program by modulating the activity of transcription factors. The regulatory activity of signalling
on GRNs can be harnessed in order to trigger the shift between cellular states for the purpose
of disease treatment or regenerative medicine.
Disease treatment in general involves the use of drugs that control the activity of specific
proteins or small molecules, improving cellular functionality. Often, drugs targets are in-
volved in signal transduction and their identification relies on the identification of differentially
expressed pathways or of upstream regulators of genes that show differential expression.
Regenerative medicine consists of multiple approaches for the restoration of functional tissues
and organs. Thanks to a combination of technological advances and improved understanding
of cellular fates determination, it is now possible to obtain almost any cell type for transplan-
tation from easily accessible cells, such as fibroblasts (J. Xu, Du, and Deng 2015). The
possibility of inducing cellular transitions with small molecules overcomes the safety risks
connected to DNA delivery methods and promises to be less expensive, non immunogenic,
and easily optimized (Pesaresi, Sebastian-Perez, and Cosma 2019).
The issue of identifying which chemical compounds can induce the intended cellular
transitions has been so far addressed by leveraging knowledge on the desired cellular
type and signalling pathways related to it, or by screening chemical compounds for the
desired effect (De et al. 2017). Both strategies are inefficient, and thus the development
of computational methods for the selection of signalling targets is desirable. The approach
presented here is a first attempt at addressing this issue in a systematic way.
Available methods for the prediction of drivers of cellular conversions predict transcription
factors that are involved in the cellular identity desired or play a key role in the gene expression
program of the initial or desired cell type (Cahan et al. 2014; D’Alessio et al. 2015; Rackham
et al. 2016; Okawa et al. 2016). On the other hand, computational methods using gene
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expression data that focus on signalling either pinpoint signalling pathways that are activated
or inhibited by a perturbation (being it a compound, or a disease condition), or identify the
specific molecules targeted by such perturbations (mode of action proteins in the case of
drugs, or disease-specific genes), without considering the regulatory role of signalling on
gene expression.
Thus, the primary contribution of this thesis is the introduction of a generally applicable
approach to predict which signalling perturbations can induce the transition between an initial
and a desired cellular gene expression state. Compared to existing tools, this approach
might predict the target of an experimentally applied perturbation, but aims more generally at
identifying any signalling perturbation that could induce the same shift in gene expression
program. In other words, its purpose is not to describe how cells respond to stimuli, but to
find which signalling stimuli could induce them to reach a desired state.
5.1 Integration of signalling and transcriptional networks
The framework used in this work differs from existing approaches by explicitly modelling the
interaction between signalling networks and GRN. The two regulatory layers are represented
using different formalisms, reflecting the inherent differences in terms of mechanism of action,
time-scale, and uncertainty associated with gene expression data.
The gene expression regulation was represented using a Boolean network model. The
GRN consists of the TFs that change their expression Boolean state between the initial and
desired cellular states, with the aim of capturing the cellular shift required for the desired
cellular transition. The inference of the correct GRN topology for each cellular transition
takes advantage of transcriptional interactions manually curated from literature (Crespo et al.
2013). This general strategy is suitable for any cellular transition because it contextualizes the
network of potential transcriptional interactions to the gene expression profile of the initial and
target cellular states, without requiring large amounts of data, manual curation, or parameter
estimation.
Gene expression levels have been used previously as measures of signalling activity,
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in methods that differ from the approach proposed here in terms of aims and integration
with transcriptional regulation. For instance, in PATHiWAYS (Sebastian-Leon et al. 2014),
signalling pathways were integrated with cellular functions such as cell cycle, growth, prolif-
eration, survival or apoptosis, and differential activation of pathways estimated from gene
expression data was used to interpret disease mechanisms.
Because the aim of this work is to induce transitions between stable cellular states, it can
be assumed that the proteins present in the initial stable state are actively expressed and not
inherited from previous cellular states, so their gene expression should be detectable. Thus,
the probability of a gene being expressed in the initial cellular state was used to define which
signalling proteins might be exploited for signal transduction, resulting in the definition of most
probably expressed signalling paths (MPPs). The inferred MPPs were consistently supported
by phosphorylation state changes in cellular transitions where phosphoproteomics data was
available. This result, although limited to six examples, indicated that it is reasonable to
use gene expression data to analyse signalling events, in the absence of perturbation or
phosphoproteomics data.
5.1.1 Prediction of signalling molecules for cellular transitions
At the interface between the signalling and GRN models, lie TFs that are regulated by
signalling pathways and regulate the expression of other genes, among which the TFs
present in the GRN. This is where the integration between the two regulatory layers takes
place. In INCanTeSIMO, the perturbations of interface TFs that best cause a shift from the
initial to desired GRN states are selected, and the initial signalling state is used to define which
signalling molecules are most likely to induce them following MPPs. Therefore, signalling
molecules are ranked according to their probability of inducing the desired GRN state. This is
in contrast to other GRN-based approaches such as DeMAND (Woo et al. 2015) that only
take into account the topology of the GRN, without considering collective changes in TF
expression induced by signalling cues. Specificity of action guides the selection of signalling
molecules: molecules that act on few effective interface TFs are preferred to others that have
an indiscriminate action.
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Small molecules and chemical compounds are increasingly used to induce cellular transi-
tions, however their mechanism of action remains in large part poorly understood, with 60%
of existing approved drugs not having annotated targets and only half of all known drug-target
pairs associated with inhibiting or activating effect (Sawada et al. 2018). For this reason,
this work did not focus on identifying chemical compounds or small molecules, and instead
INCanTeSIMO was developed with the objective of considering each signalling molecule in
the network as equally capable of inducing the desired cellular transitions.
In the light of this incomplete knowledge, the success rate obtained by INCanTeSIMO in
predicting direct targets of experimental perturbations (61%) is satisfactory. Furthermore, the
method outperformed other available approaches, such as Connectivity Map and DeMAND. In
comparison to Connectivity Map, the main advantage of INCanTeSIMO is the independence
from pre-collected gene expression signatures, which severely affected Connectivity Map’s
performance in the analysis of novel cellular transitions. With regards to DeMAND, INCan-
TeSIMO obtained comparable performance while requiring significantly less data samples,
and it also specifies if the predicted molecules should be activated or inhibited. Thus, the
approach followed here offers the best balance between the amount of data required as input
and the performance and type of predictions obtained.
5.1.2 Pathway perturbations for cellular transitions
Given that for many signalling molecules there might be no activators and inhibitors reported,
it is beneficial to also predict signalling pathways triggering cellular conversions. In particular,
as chemical inhibitors and activators for specific members of each pathway are well known
(Lis, Kuzawin´ska, and Bałkowiec-Iskra 2014; Moreira, Fernandes, and Ramos 2007; Tamm et
al. 2000; F. H. Tran and J. J. Zheng 2017), it is useful to predict pathways with the expectation
that any perturbation applied to them will induce the cellular conversion required. Numerous
pathways prediction tools exist, which aim at identifying signalling pathways involved in
disease, cellular response to stimuli, cellular conversions etc. However, the majority of
these approaches select pathways based on their gene expression differences between
two compared conditions. This leads to uncertainty as to whether the observed expression
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change is the outcome or the driver of a switch in gene regulatory program.
INCanTeSIMO path identifies pathways by calculating the aggregate source/sink centrality
of INCanTeSIMO candidate molecules, under the assumption that if molecules that are central
to a pathway are able to induce the cellular conversion required, the other components of the
pathway can exert the same effect. Source/sink centrality (Naderi Yeganeh and Mostafavi
2019) measures the importance of molecules in a pathway based on how often they are
used as the initial or final point in directed signal transduction paths. Thus, the pathway score
used in INCanTeSIMO path is not a measure of over-representation of the components of
a signalling pathway in a set of significant genes, as in enrichment-based tools, but takes
into account the role of the candidate molecules in the pathway, according to its topology
and directionality. INCanTeSIMO path showed better performance than other methods
based on differential expression inputs or enrichment measures, and its predictions could be
systematically confirmed by literature review.
One important caveat in predicting signalling pathways is their loose definition: canonical
signalling pathways are highly variable depending on the database used (Kirouac et al. 2012;
Tu¨rei, Korcsma´ros, and Saez-Rodriguez 2016) and subject to extensive crosstalk (Schaefer
et al. 2009). Thus, the prediction of some pathways according to source/sink centrality might
present artefacts if candidate molecules are shared between multiple signalling pathways,
and results could change according to the pathway database used. The predictions obtained
should be interpreted taking into account which candidate molecules caused the prediction of
a particular pathway.
5.2 Advantages of this approach
As mentioned previously, the use of manually curated transcriptional interactions for the
inference of GRN allows to analyse cellular transitions for which few single expression profiles
are available per cellular state. Depending on the type of data, which defines which approach
for gene expression Booleanization and probability estimation can be applied, as low as one
sample per state is sufficient for obtaining predictions. Additionally, as only the initial signalling
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state is considered (by estimating the probability of expression of signalling molecules in
the initial cellular state), cellular transitions that have not yet been obtained in vitro can be
analysed too, by comparing primary cell states. Thus, this approach is extremely flexible and
generally applicable to any kind of biological process where cellular transitions are involved.
In the same vein, and unlike ad hoc models for specific cell types, no prior biological
knowledge on the cellular transition desired is required as input. This was most evident in
the application of INCanTeSIMO to a liver cirrhosis model in rat, resulting in the prediction of
many signalling molecules associated with the disease, and among them the activation of
Tie2, a receptor for angiopoietins involved in the stabilization of blood vessels (Fagiani and
Christofori 2013). The GRN TFs expected to change upon Tie2 activation were identified via
simulations, and literature review revealed their involvement in angiogenesis. Experimental
observations confirmed that some of these TFs shifted towards their healthy expression state
upon treatment with an agonist of Tie2, which has previously been shown to improve blood
vessels stability (Pauta et al. 2015). Therefore, while INCanTeSIMO only required the disease
and healthy gene expression profiles as input, it was able to identify signalling molecules
and corresponding TFs related to the same specific biological process, also involved in the
disease, and whose perturbation improved the pathological state.
Overall, novel predictions obtained with INCanTeSIMO and INCanTeSIMO path were
regularly related both to experimentally validated perturbations and to the cellular transi-
tion considered. Importantly, the methods correctly predicted signalling targets for cellular
differentiation and reprogramming, which represent a key aspect of regenerative medicine.
Similarly the predictions obtained for the initial steps of limb regeneration in the salamander
A. mexicanum consistently recapitulated existing knowledge and previous observations, cap-
turing the signalling cues that are known to come from dermis, nerves and other cells and
act on the Prrx1-expressing connective tissue cells. In summary, the integration of signalling
network and GRN, by explicitly modelling the regulatory activity of signalling on transcription,
allowed capturing consistently signalling molecules and pathways that can trigger the cellular
transition desired.
99
CHAPTER 5. DISCUSSION AND PERSPECTIVES
5.3 Limitations
The current implementation is computationally intensive. For this reason, combinations of
only up to 4 interface TFs could be exhaustively perturbed in silico. Although there are hardly
any synergistic effects among low-efficiency TFs in the combination of this size inducing
significant change of the GRN state, it cannot be discarded that this might happen in higher
order combinations. Other computationally intensive tasks include the calculation of the most
probable paths connecting each signalling molecule to all interface TFs.
This approach cannot be applied to the analysis of very similar cellular states, or in
general cellular conversions that show changes in gene expression for TFs that are not
interacting among them to form a connected GRN of reasonable size (at least 10 TFs).
From the biological point of view, the inference of small, disconnected GRNs suggests that
the differences between initial and desired cellular states cannot be recapitulated by the
propagation of a signalling perturbation across a GRN model. Rather, the differences in
gene expression might be caused indirectly by perturbations which act at the level of other
biological processes (e.g. metabolic pathways), and result in gene expression changes
by affecting isolated TFs and their regulation of non-TF targets. With the same principle,
datasets where no perturbation of the interface TFs can induce changes in at least 40% of
the GRN TFs cannot be reliably analysed with this approach.
5.3.1 Issues with validation
A major issue in testing computational methods is the validation of obtained predictions. In
this case, the methods were applied to known cellular transitions associated with a specific
single signalling perturbation, being it a growth factor, chemical compound or small molecule
applied to the cells. As mentioned previously, the majority of drugs approved for clinical use
do not have known targets (Sawada et al. 2018), which also suggests that even drugs with
associated targets might have unknown targets. Among the known and unknown targets,
it is unclear which ones are drivers of the cellular response observed. Therefore, only
perturbations with at least one known target were considered, and a successful prediction
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was defined as the selection of at least one signalling molecule or pathway directly targeted
by the perturbation.
Another source of uncertainty is the fact that multiple alternative perturbations might
induce the same cellular conversion. As first step into considering this possibility, the similarity
of predicted perturbations to the experimentally tested ones was assessed. This analysis
showed that there are functional and topological similarities among the predictions and the
experimentally applied perturbations. However, unrelated perturbations might also induce the
same cellular state, either because they share the same downstream effectors, or because
they can act on different parts of the GRN that regulate each other resulting in the same GRN
state. This became evident in the pathway analysis of cell fate transitions: through literature
review, the potential of inducing the cellular transition was confirmed extensively for pathways
not affected by the experimental perturbation.
The increasing number of signalling perturbations able to induce cellular transitions will
allow to validate more extensively candidate pathways or molecules predicted by compu-
tational methods, but ultimately there is a need for large-scale screenings of perturbations
that can induce cellular transitions in healthy cell types, expanding from the cancer cell line
perturbation repositories currently available (Xiao et al. 2015; Subramanian, Narayan, et al.
2017).
5.3.2 Applicability to different data types
The expression state and probability play a central role in the analysis, as both the GRN
and the signalling network are contextualized to the cellular transitions using them. Their
estimation should therefore be performed as accurately as possible. All gene expression data
used in this work was obtained by microarray. For specific microarray platforms, the datasets
available in public repositories are so abundant that reliable estimation of the expression
values range is possible for each gene separately (Matthew N. McCall, Bolstad, and Rafael A.
Irizarry 2010)(frmaBool strategy). For datasets generated using Affymetrix chips, the MAS5.0
algorithm can estimate if a gene is expressed above background noise levels. However, to
obtain a general approach for Booleanization, a data-driven strategy was devised (geneDE).
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While the geneDE Booleanization approach cannot account for different dynamic ex-
pression ranges among genes and requires replicates for each cellular state, it relies on
well established differential expression analysis pipelines and is extremely flexible. This
strategy can readily be applied to RNA sequencing (RNA-seq) data. An alternative and more
precise approach would be to use large databases of RNA-seq experiments, homogeneously
pre-processed, to define gene-specific expression distributions. Multiple such databases
already exist for human, mouse and rat (Lachmann et al. 2018; So¨llner et al. 2017). A strategy
similar to the one used in RefBool (Jung et al. 2017) could be applied to determine if genes
are expressed or not and to calculate the probability of expression for each gene, allowing
the use of INCanTeSIMO on RNA-seq data.
5.4 Outlook
5.4.1 Heterogeneity in the cellular response to signals
Cell-to-cell differences in the response to the same stimulus are ubiquitous and caused
by pre-existing differences among cells (Selimkhanov et al. 2014; Toettcher, Weiner, and
Lim 2013). These differences can be explained with the existence of clusters of different
cellular functional states (subpopulations) (Snijder et al. 2009), which are observed in both
signalling dynamics and gene expression patterns (Lane et al. 2017). The existence of
different subpopulations implies that the same signalling stimulus might induce the cellular
conversion desired only in portions of the cells, resulting in low conversion efficiency.
Using single cell RNA sequencing data, it is possible to identify sub-populations of cells
with different functional state. This in turn could be used to define which specific signalling
cues are required by each of them in order to induce the desired cellular transition, resulting
in overall higher conversion efficiency.
The approach presented here could be adapted to use the gene expression patterns
of each subpopulation separately. The expression of a gene across the cells in a subpop-
ulation could help define if it is expressed or not, and its probability of expression. Then, a
subpopulation-specific GRN could be reconstructed with the use of GRN inference methods
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developed for bulk (Faith et al. 2007; Huynh-Thu et al. 2010; Margolin et al. 2006) or single
cell data (Aibar et al. 2017; Chan, Stumpf, and Babtie 2017). Finally, the paths most likely
connecting signalling molecules and interface TFs could be identified, integrating in the
calculation the gene expression correlation of the proteins involved in the paths in each
subpopulation. This would result in different interface TFs and signalling paths available for
signal transduction in each subpopulation, and thus in specialized predictions.
5.4.2 Relation with other mechanisms regulating gene expression
Cellular conversions can be induced also by acting on the cells metabolism or epigenetic
landscape. The methods presented are not suitable in their current form for the discovery of
this type of interventions, as metabolic or epigenetic regulation are not taken into account.
However, they could be integrated in the current modelling framework.
Metabolism can regulate gene expression by exerting direct and indirect control on chro-
matin (Hong Li et al. 2018). Additionally, the energetic balance of the cells can influence
gene expression, and the induction of glycolysis or autophagy was shown to improve repro-
gramming of cells to iPSCs in combination with TFs (T. Chen et al. 2011; Zhu et al. 2010).
Thus, the metabolic regulation of the GRN can be represented as mediated by the signalling
pathways sensing the metabolic state of the cells, such as AMPK (Burkewitz, Y. Zhang, and
Mair 2014), mTOR (Kennedy and Lamming 2016), autophagy and hypoxia pathways, and
could be improved by modelling of chromatin role on gene expression.
Recently, the development of CRISPR/Cas9 systems for epigenetic modification have
simplified and made accessible targeted epigenetic editing (Jeffries 2018). Remaining
challenges for this approach are the delivery of the machinery necessary for these systems
inside the cells, and the possibility of regulating multiple target genes at the same time.
The cell epigenetic landscape can also be regulated by modulating the activity of DNA
methyltransferases or histone-modifying enzymes like acetyltransferases, deacetylases, and
methyltransferases with chemical compounds. This strategy was already used in disease
treatment (Wouters and Delwel 2016) and cellular reprogramming (E. Li and Davidson 2009;
Shi et al. 2008; K. A. Tran et al. 2015). Further advancements in the understanding of pioneer
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transcription factors, which are able to bind the DNA and exert their function even when the
chromatin is not accessible (Iwafuchi-Doi and Zaret 2014), might in the future lead to the
development of general methods for the prediction of combinations of TFs and chemical
compounds that can trigger desired cellular conversions.
Epigenetic editing (via targeted systems, pioneer factors or enzymes modulation) might
be included in the scope of the present method by including in the GRN model the epigenetic
state of the TFs. Provided the availability of epigenetic data such as DNA methylation, histone
acetylation or methylation, the epigenetic profile of the initial and desired cellular state could
be delineated and compared. In particular, considering the accessibility and activity state
of the regulatory regions of the TFs in the GRN, it would be possible to predict if changes
to these properties are needed to obtain the desired gene expression profile, and which
compounds or TFs are suitable for the purpose of inducing them.
5.4.3 Prediction of signal combinations
An important limitation of the methods at present is that they only estimate the effect of single
candidate molecules or pathways, whereas combinations of them normally reach higher
cellular conversion efficiency (Cao et al. 2016; Kunisada et al. 2012). Indeed, established
experimental protocols for the induction of cellular conversions often consist of multiple
molecules applied in cocktails (Lai et al. 2017).
An initial attempt to predict combinations of molecules according to their addictive activity
on interface TFs proved unsuccessful. This suggests that in reality, a key point for prediction
of combinations will be understanding the interplay of different signal transduction paths.
Signalling pathways are not isolated components, but are embedded in a signalling network
where protein-protein interactions are free to occur and are stochastic events (Ladbury and
Arold 2012), giving rise to extensive cross-talk opportunities.
A strategy that takes into account such cross-talk at the level of signalling network is
necessary. Different molecules might use the same path to act on common downstream
molecules, reinforcing the activation or inhibition of the interface TFs downstream, or might
be redundant. Furthermore, different signalling molecules might have a synergistic effect and
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induce the activation or inhibition of interface TFs in ways that are not deducible from their
individual effects (Housden and Perrimon 2014).
In order to extend the current approach to account for signalling cross-talk, it would be
necessary to consider not only the probability and sign of the most probably expressed paths
between signalling molecules and interface TFs, but also the intermediate molecules used in
such paths. To discriminate between redundant, additive and synergistic effects, however,
extensive knowledge on the logic rules governing the activation or inhibition of signalling
molecules is required. While this knowledge might be available for canonical signalling paths,
non-canonical signal transduction has been shown repeatedly to be a prominent regulator of
gene expression (Meyerovich et al. 2016; Ohta et al. 2016; Regan et al. 2017; Voloshanenko
et al. 2018) and is not as thoroughly documented so far. A possible alternative might be to
define general logic rules governing classes of molecules, for example based on their mode
of action or protein super-family.
5.5 Conclusion
The ability to induce transitions between cellular states is necessary for disease modelling
and regenerative medicine. Cellular states are recapitulated by gene expression patterns,
which are maintained by GRNs. In turn, changes in GRN state are reflected in differences in
cellular functionality and possibly cellular identity. Not only transcriptional regulators, but also
signalling events can regulate the state of the GRN by modulating the activity of interface
TFs. The use of chemical compounds and small molecules targeting signalling pathways in
order to induce cellular transitions is gaining more attention because of its advantages in
terms of reproducibility, controllability, and safety compared to other strategies. However, the
discovery of compounds for cellular transitions still relies on screenings or guidance from
existing knowledge, and would benefit from predictive computational methods.
At present, existing computational methods focus separately on GRN or signalling net-
works. A number of tools exist for the prediction of instructive transcriptional factors that
can induce cellular transitions. Additionally, methods that focus on the signalling network to
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describe how changes in gene expression affect signal transduction are also available. A
reduced number of methods consider the action of signalling cues on their downstream TFs,
but only manually curated and ad hoc models exist that integrate signalling and transcriptional
networks. The aim of this work was to develop a general approach to analyse the effect
that signalling cues have on the GRN by using gene expression data. In conclusion, the
significant points of this thesis are:
• Gene expression probability can reasonably approximate signal transduction. Transcrip-
tomics and phosphoproteomics data show at best a moderate correlation. However,
the expression of proteins that constitute a signalling path is the first condition for
signal transduction to happen along such path. It was observed that the most probably
expressed paths connecting perturbation targets and interface TFs tend to show sig-
nificantly more phosphorylation changes as compared to other paths, suggesting that
paths preferentially used for signal transduction can be inferred using gene expression
data.
• Integration of regulatory layers can be obtained with gene expression data. The pro-
posed approach consisted in the integration of two distinct models for the transcriptional
and signalling regulatory layers. The stochasticity of signal transduction and its effect
on the interface TFs were taken into account by the use of a probabilistic approximation
of signal transduction, and the role of interface TFs in determining the state of the GRN
was estimated by in silico perturbations of a Boolean network model.
• Signalling perturbations for cellular transitions can be consistently predicted with this
approach. The prediction of candidate molecules is based on the specificity with which
signalling molecules are predicted to activate and inhibit the interface TFs that regulate
the GRN state, calculated by Jensen-Shannon’s divergence. The results obtained
showed better performance compared to other methods in recovering experimental
perturbations, and functional and topological characteristics shared with targets of
such perturbations. Signalling pathways were predicted by calculating the aggregate
importance of candidate molecules, expressed in terms of source/sink centrality, in
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each pathway. Again, the performance obtained was superior to previously published
methods. Candidate molecules and pathways are associated with a sign, to further
guide the design of experiments for the induction of the desired cell state shift.
• Previous knowledge was consistently recapitulated in the predictions. Extensive liter-
ature review confirmed that the molecules and pathways predicted for the induction
of multiple and diverse cellular transitions. The approach was applied to multiple ex-
amples of cellular differentiation and reprogramming, but also the reversal of disease
phenotypes and to limb regeneration in animal models, confirming its general scope
and general applicability.
• The effect of signalling on the GRN was validated experimentally. The application of this
method to the prediction of signalling molecules for the treatment of cirrhosis resulted
in the selection of CVX-060, an agonist of the receptor Tie2. As predicted, it induced
changes in the expression of GRN TFs involved in cirrhotic processes.
In conclusion, the methods presented here represent a useful addition to the existing
computational tools for cellular conversions. They are generally applicable tools that can
direct the identification of signalling molecules and pathways for the induction of desired
cellular transitions, such as the induction of cellular differentiation or reprogramming and the
reversal of pathological phenotypes, without needing biological knowledge of the cellular
conversion studied to be given as input. The potential applications of this approach include
disease treatment and regenerative medicine.
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7 Appendices
Table 7.1: Canonical pathways present in MetaCore from Clarivate Analytics included in the signalling
network.
Class Pathway Short name
Signal transduction Androgen receptor nuclear signaling ARnuc
Signal transduction Androgen receptor signaling cross-talk ARcross
Signal Transduction BMP and GDF signaling BMP
Signal Transduction Cholecystokinin signaling cholecystokinin
Signal transduction CREM pathway CREM
Signal transduction ERBB-family signaling ERBB
Signal transduction ESR1-membrane pathway ESR1membr
Signal transduction ESR1-nuclear pathway ESR1nucl
Signal transduction ESR2 pathway ESR2
Signal transduction Insulin signaling insulin
Signal transduction Leptin signaling leptin
Signal transduction Neuropeptide signaling pathways neuropeptides
Signal transduction Nitric oxide signaling NO
Signal transduction NOTCH signaling NOTCH
Signal transduction Oxytocin signaling oxytocin
Signal Transduction TGF-beta, GDF and Activin signaling TGFb
Signal transduction WNT signaling Wnt
Inflammation Amphoterin signaling amphoterin
Inflammation Complement system compl
Inflammation Histamine signaling histamine
Inflammation IFN-gamma signaling IFN
Inflammation IgE signaling IgE
Inflammation IL-10 anti-inflammatory response IL10
Inflammation IL-12,15,18 signaling IL12
Inflammation IL-13 signaling pathway IL13
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Inflammation IL-2 signaling IL2
Inflammation IL-4 signaling IL4
Inflammation IL-6 signaling IL6
Inflammation Inflammasome inflammasome
Inflammation Innate inflammatory response innate
Inflammation Interferon signaling interferon
Inflammation Jak-STAT Pathway JAKSTAT
Inflammation Kallikrein-kinin system kallikrein
Inflammation MIF signaling MIF
Inflammation Neutrophil activation neutrophil
Inflammation NK cell cytotoxicity NK
Inflammation Protein C signaling proteinC
Inflammation TREM1 signaling TREM1
Response to hypoxia and ox-
idative stress
hypoxia
Immune response Antigen presentation antigen
Immune response BCR pathway BCR
Immune response IL-5 signalling IL5
Immune response Innate immune response to RNA viral infection RNAviral
Immune response Phagocytosis phagocytosis
Immune response Phagosome in antigen presentation phagosome
Immune response T helper cell differentiation Th
Immune response TCR signaling TCR
Immune response Th17-derived cytokines Th17
Apoptosis Anti-Apoptosis mediated by external signals by Estrogen apop-estrogen
Apoptosis Anti-Apoptosis mediated by external signals via MAPK
and JAK/STAT
apop-MAPK
Apoptosis Anti-apoptosis mediated by external signals via NF-kB apop-NFkB
Apoptosis Anti-Apoptosis mediated by external signals via
PI3K/AKT
apop-PI3K
Apoptosis Apoptosis stimulation by external signals apop-external
Apoptosis Death Domain receptors & caspases in apoptosis death
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Apoptosis Endoplasmic reticulum stress pathway ERstress
Development Blood vessel morphogenesis bloodVessel
Development Regulation of angiogenesis angiogenesis
Development Cartilage development cartilage
Development Hedgehog signaling HH
Development Regulation of telomere length telomere
Development Regulation of epithelial-to-mesenchymal transition EMT
Development Keratinocyte differentiation keratinocyte
Development Melanocyte development and pigmentation melanocyte
Cardiac development BMP-TGF beta signaling cardiac-BMP
Cardiac development FGF-ErbB signaling cardiac-FGF
Cardiac development Role of NADPH oxidase and ROS cardiac-NADPH
Cardiac development Wnt-beta-catenin, Notch, VEGF, IP3 and integrin signal-
ing
cardiac-Wnt
Development Hemopoiesis, Erythropoietin pathway hemopoiesis
Development Skeletal muscle development muscle
Development ERK5 in cell proliferation and neuronal survival ERK5
Development Neurogenesis in general neurogenesis
Development Neurogenesis-Axonal guidance axonal
Development Neurogenesis-Synaptogenesis synaptogenesis
Development Neuromuscular junction neuromuscular
Development Ossification and bone remodeling ossification
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Table 7.2: Signalling interactions manually removed from the signalling network after literature review
from to Effect Mechanism
ADAM17 ErbB4 = ErbB4(CTF) Activation Cleavage
gamma-Secretase complex ErbB4(CTF) = ErbB4(ICD) Activation Cleavage
AKT(PKB) SMAD7 Inhibition Binding
TGF-beta receptor type I SMAD7 Activation Binding
SNAIL1 ID1 Activation Binding
SMAD4 BRG1 Activation Binding
ESR1 (nuclear) PPAR-gamma Inhibition Binding
PPAR-gamma STAT3 Inhibition Binding
SMAD3 MYOG Inhibition Binding
PKC-alpha PPAR-alpha Inhibition Phosphorylation
SMAD4 HNF4-alpha Activation Binding
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Table 7.3: List of datasets analysed bu INCanTeSIMO. Type is either cm = datasets extracted from
ConnectivityMap build 02 (Lamb et al. 2006), ae = datasets manually extracted from ArrayExpress
corresponding to cell state transitions, pp = datasets for which phosphoproteomics data was available,
or cf = datasets corresponding to cell fate transitions. Subfix is the internal subfix used for analysis. t =
time after perturbation (h). NP = number of direct perturbation targets present in the signalling network.
BR = ranking obtained by the best of them, NS = number of signalling molecules selected at 6% of the
maximum rank (number of candidate molecules), success = correct prediction of any perturbation
target among the selected candidates (T=true,F=false), NC = number of correctly predicted direct
perturbation targets.
Type GEO id perturbation t cell type array platform NP BR NS successNC
cm valproic acid 6 MCF7 HG-U133A 12 685 299 F 0
cm alpha-estradiol 6 MCF7 HG-U133A 40 20 308 T 1
cm tamoxifen 6 MCF7 HG-U133A 41 13 272 T 6
cm dexverapamil 6 MCF7 HG-U133A 8 316 233 F 0
cm sulindac 6 MCF7 HG-U133A 13 282 252 F 0
cm tacrolimus 6 MCF7 HG-U133A 20 25 320 T 1
cm rofecoxib 6 MCF7 HG-U133A 7 9 350 T 1
cm celecoxib 6 MCF7 HG-U133A 4 74 299 T 1
cm SC-58125 6 MCF7 HG-U133A 3 268 293 F 0
cm tanespimycin 6 MCF7 HG-U133A 18 84 317 T 2
cm rofecoxib 6 MCF7 HG-U133A 7 159 254 T 1
cm indometacin 6 MCF7 HG-U133A 50 115 257 T 2
cm prednisolone 6 MCF7 HG-U133A 37 88 305 T 1
cm thalidomide 6 MCF7 HG-U133A 9 151 278 T 1
cm genistein 6 MCF7 HG-U133A 22 43 387 T 1
cm genistein 6 MCF7 HG-U133A 22 10 267 T 3
cm fludrocortisone 6 MCF7 HG-U133A 2 158 257 T 1
cm NU-1025 6 MCF7 HG-U133A 7 129 281 T 1
cm acetylsalicylic acid 6 MCF7 HG-U133A 34 195 196 F 0
cm LY-294002 6 MCF7 HG-U133A 22 13 253 T 5
cm sirolimus 6 MCF7 HG-U133A 19 110 300 T 1
cm LY-294002 6 MCF7 HG-U133A 22 38 311 T 5
cm trichostatin A 6 MCF7 HG-U133A 18 23 236 T 3
cm trichostatin A 6 MCF7 HG-U133A 18 86 287 T 1
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cm diclofenac 6 MCF7 HG-U133A 18 284 294 F 0
cm nifedipine 6 MCF7 HG-U133A 6 123 293 T 1
cm felodipine 6 MCF7 HG-U133A 5 318 273 F 0
cm valproic acid 6 MCF7 HG-U133A 12 6 292 T 1
cm valproic acid 6 MCF7 HG-U133A 12 39 356 T 1
cm valproic acid 6 MCF7 HG-U133A 12 79 275 T 1
cm LY-294002 6 HL60 HG-U133A 22 2 312 T 2
cm sirolimus 6 HL60 HG-U133A 19 32 301 T 2
cm fulvestrant 6 MCF7 HG-U133A 7 198 356 F 0
cm rosiglitazone 6 HL60 HG-U133A 15 330 280 F 0
cm troglitazone 6 HL60 HG-U133A 6 143 288 T 1
cm raloxifene 6 ssMCF7 HG-U133A 39 86 295 T 1
cm tamoxifen 6 MCF7 HG-U133A 41 136 330 T 1
cm tanespimycin 6 MCF7 HG-U133A 18 114 274 T 2
cm genistein 6 MCF7 HG-U133A 22 84 293 T 1
cm raloxifene 6 HL60 HG-U133A 39 163 357 T 1
cm wortmannin 6 HL60 HG-U133A 28 320 371 F 0
cm sirolimus 6 ssMCF7 HG-U133A 19 67 402 T 2
cm alpha-estradiol 6 ssMCF7 HG-U133A 40 27 262 T 1
cm wortmannin 6 ssMCF7 HG-U133A 28 44 292 T 3
cm valproic acid 6 HL60 HG-U133A 12 99 343 T 1
cm nordihydroguaiaretic
acid
6 ssMCF7 HG-U133A 3 866 298 F 0
cm thioridazine 6 MCF7 HG-U133A 26 130 268 T 1
cm haloperidol 6 MCF7 HG-U133A 36 69 333 T 5
cm tanespimycin 6 MCF7 HG-U133A 18 6 328 T 2
cm LY-294002 6 PC3 HG-U133A 22 36 283 T 3
cm rosiglitazone 6 PC3 HG-U133A 15 49 374 T 1
cm troglitazone 6 PC3 HG-U133A 6 142 390 T 1
cm tanespimycin 6 PC3 HG-U133A 18 1 336 T 1
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cm arachidonic acid 6 MCF7 HG-U133A 10 1 228 T 2
cm oligomycin 6 MCF7 HG-U133A 2 1137 327 F 0
cm arachidonic acid 6 MCF7 HG-U133A 10 120 225 T 1
cm trichostatin A 6 PC3 HG-U133A 18 6 240 T 1
cm monorden 6 PC3 HG-U133A 12 27 239 T 1
cm tanespimycin 6 PC3 HG-U133A 18 2 282 T 3
cm indometacin 6 PC3 HG-U133A 50 3 350 T 5
cm prochlorperazine 6 MCF7 HG-U133A 19 7 238 T 3
cm valproic acid 6 PC3 HG-U133A 12 44 294 T 1
cm LY-294002 6 PC3 HG-U133A 22 77 268 T 1
cm troglitazone 6 PC3 HG-U133A 6 13 269 T 1
cm monorden 6 PC3 HG-U133A 12 34 210 T 3
cm fluphenazine 6 MCF7 HG-U133A 21 13 314 T 2
cm iloprost 6 SKMEL5 HG-U133A 9 62 261 T 1
cm LY-294002 6 SKMEL5 HG-U133A 22 149 476 T 1
cm SC-58125 6 SKMEL5 HG-U133A 3 313 237 F 0
cm tanespimycin 6 ssMCF7 HG-U133A 18 113 288 T 1
cm nordihydroguaiaretic
acid
6 ssMCF7 HG-U133A 3 153 322 T 1
cm geldanamycin 6 MCF7 HG-U133A 7 163 264 F 0
cm resveratrol 6 MCF7 HG-U133A 49 56 288 T 6
cm thalidomide 6 MCF7 HG-U133A 9 125 279 T 1
cm NU-1025 6 MCF7 HG-U133A 7 82 253 T 1
cm geldanamycin 6 MCF7 HG-U133A 7 44 357 T 2
cm pentamidine 6 MCF7 HG-U133A 4 843 279 F 0
cm resveratrol 6 PC3 HG-U133A 49 85 230 T 2
cm alpha-estradiol 6 PC3 HG-U133A 40 172 250 F 0
cm genistein 6 PC3 HG-U133A 22 152 240 F 0
cm fulvestrant 6 PC3 HG-U133A 7 127 395 T 2
cm alpha-estradiol 6 MCF7 HG-U133A 40 3 270 T 2
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cm colforsin 6 HL60 HG-U133A 30 203 204 F 0
cm naltrexone 6 HL60 HG-U133A 4 1245 358 F 0
cm astemizole 6 HL60 HG-U133A 13 191 306 F 0
cm gallamine triethio-
dide
6 HL60 HG-U133A 9 429 345 F 0
cm nomifensine 6 HL60 HG-U133A 6 229 296 F 0
cm nalbuphine 6 HL60 HG-U133A 6 1844 298 F 0
cm spironolactone 6 HL60 HG-U133A 4 444 356 F 0
cm terfenadine 6 HL60 HG-U133A 5 134 297 T 1
cm mianserin 6 HL60 HG-U133A 24 244 287 F 0
cm pirenzepine 6 HL60 HG-U133A 7 269 342 F 0
cm thioproperazine 6 HL60 HG-U133A 8 1335 307 F 0
cm pindolol 6 HL60 HG-U133A 6 586 335 F 0
cm trichostatin A 6 HL60 HG-U133A 18 94 323 T 1
cm thalidomide 6 HL60 HG-U133A 9 843 306 F 0
cm tiratricol 6 HL60 HG-U133A 38 158 350 T 1
cm tranylcypromine 6 HL60 HG-U133A 2 Inf 304 F 0
cm flufenamic acid 6 HL60 HG-U133A 10 23 329 T 2
cm trichostatin A 6 HL60 HG-U133A 18 106 285 T 4
cm xylometazoline 6 HL60 HG-U133A 10 436 330 F 0
cm nimesulide 6 HL60 HG-U133A 5 525 310 F 0
cm oxymetazoline 6 HL60 HG-U133A 14 356 293 F 0
cm tolfenamic acid 6 HL60 HG-U133A 2 736 303 F 0
cm labetalol 6 HL60 HG-U133A 15 24 263 T 1
cm oxybutynin 6 HL60 HG-U133A 6 21 347 T 1
cm clonidine 6 HL60 HG-U133A 9 507 252 F 0
cm cinnarizine 6 HL60 HG-U133A 14 157 370 T 2
cm spiperone 6 HL60 HG-U133A 18 151 358 T 1
cm trichostatin A 6 HL60 HG-U133A 18 235 316 F 0
cm pimozide 6 HL60 HG-U133A 22 311 353 F 0
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cm mepacrine 6 HL60 HG-U133A 3 808 315 F 0
cm clomipramine 6 HL60 HG-U133A 20 325 308 F 0
cm mifepristone 6 HL60 HG-U133A 37 218 271 F 0
cm alprenolol 6 HL60 HG-U133A 14 4 316 T 1
cm fluphenazine 6 HL60 HG-U133A 21 144 338 T 1
cm ketotifen 6 HL60 HG-U133A 5 62 337 T 1
cm methapyrilene 6 HL60 HG-U133A 5 48 354 T 2
cm dobutamine 6 HL60 HG-U133A 16 36 311 T 3
cm betamethasone 6 HL60 HG-U133A 39 54 301 T 1
cm ketanserin 6 HL60 HG-U133A 12 8 365 T 2
cm zidovudine 6 HL60 HG-U133A 11 11 366 T 1
cm desipramine 6 HL60 HG-U133A 18 437 302 F 0
cm hemicholinium 6 HL60 HG-U133A 4 507 280 F 0
cm phenylpropanolamine 6 HL60 HG-U133A 8 461 284 F 0
cm metergoline 6 HL60 HG-U133A 20 42 297 T 1
cm clenbuterol 6 HL60 HG-U133A 10 219 299 F 0
cm maprotiline 6 HL60 HG-U133A 13 73 370 T 2
cm dosulepin 6 HL60 HG-U133A 6 732 271 F 0
cm resveratrol 6 HL60 HG-U133A 49 15 283 T 3
cm budesonide 6 HL60 HG-U133A 7 82 318 T 1
cm chloroquine 6 HL60 HG-U133A 4 731 278 F 0
cm bromperidol 6 HL60 HG-U133A 5 179 326 T 1
cm etamivan 6 HL60 HG-U133A 8 38 358 T 2
cm cyclizine 6 HL60 HG-U133A 5 245 295 F 0
cm trichostatin A 6 HL60 HG-U133A 18 7 288 T 5
cm tubocurarine chlo-
ride
6 HL60 HG-U133A 28 121 301 T 1
cm dihydroergocristine 6 HL60 HG-U133A 20 1198 306 F 0
cm papaverine 6 HL60 HG-U133A 9 389 324 F 0
cm tetrahydroalstonine 6 HL60 HG-U133A 4 913 343 F 0
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cm harmine 6 HL60 HG-U133A 16 7 278 T 1
cm cytisine 6 HL60 HG-U133A 26 287 362 F 0
cm atropine 6 HL60 HG-U133A 17 30 307 T 2
cm physostigmine 6 HL60 HG-U133A 11 1637 257 F 0
cm berberine 6 HL60 HG-U133A 11 488 317 F 0
cm trichostatin A 6 HL60 HG-U133A 18 65 333 T 4
cm quipazine 6 HL60 HG-U133A 35 472 253 F 0
cm sulfathiazole 6 PC3 HG-U133A 2 1053 303 F 0
cm amiloride 6 PC3 HG-U133A 5 250 366 F 0
cm trichostatin A 6 PC3 HG-U133A 18 153 343 T 1
cm levodopa 6 PC3 HG-U133A 3 649 271 F 0
cm thioridazine 6 PC3 HG-U133A 30 92 330 T 7
cm captopril 6 PC3 HG-U133A 17 210 344 F 0
cm diflunisal 6 PC3 HG-U133A 1 Inf 416 F 0
cm lidocaine 6 PC3 HG-U133A 16 1 256 T 2
cm naloxone 6 PC3 HG-U133A 13 300 289 F 0
cm bromocriptine 6 PC3 HG-U133A 12 41 252 T 4
cm amoxapine 6 PC3 HG-U133A 12 17 219 T 2
cm dipyridamole 6 PC3 HG-U133A 3 504 314 F 0
cm edrophonium chlo-
ride
6 PC3 HG-U133A 2 740 329 F 0
cm cyproheptadine 6 PC3 HG-U133A 21 41 293 T 2
cm ciprofloxacin 6 PC3 HG-U133A 14 53 286 T 2
cm famotidine 6 PC3 HG-U133A 2 46 313 T 1
cm loperamide 6 PC3 HG-U133A 28 266 286 F 0
cm trichostatin A 6 PC3 HG-U133A 18 65 284 T 5
cm danazol 6 PC3 HG-U133A 9 50 350 T 1
cm perphenazine 6 PC3 HG-U133A 19 8 353 T 3
cm paclitaxel 6 PC3 HG-U133A 9 1118 332 F 0
cm lisuride 6 PC3 HG-U133A 25 57 220 T 1
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cm sulfathiazole 6 HL60 HG-U133A 2 2127 304 F 0
cm sulpiride 6 HL60 HG-U133A 5 614 279 F 0
cm amiloride 6 HL60 HG-U133A 5 297 319 F 0
cm pyrimethamine 6 HL60 HG-U133A 4 777 329 F 0
cm dicycloverine 6 HL60 HG-U133A 6 106 323 T 1
cm thioridazine 6 HL60 HG-U133A 30 90 353 T 1
cm captopril 6 HL60 HG-U133A 17 2 318 T 1
cm diflunisal 6 HL60 HG-U133A 1 Inf 339 F 0
cm apomorphine 6 HL60 HG-U133A 16 29 342 T 1
cm naloxone 6 HL60 HG-U133A 13 321 283 F 0
cm bromocriptine 6 HL60 HG-U133A 12 17 247 T 1
cm amoxapine 6 HL60 HG-U133A 12 233 279 F 0
cm loxapine 6 HL60 HG-U133A 24 267 320 F 0
cm dipyridamole 6 HL60 HG-U133A 3 803 308 F 0
cm edrophonium chlo-
ride
6 HL60 HG-U133A 2 906 335 F 0
cm ciprofloxacin 6 HL60 HG-U133A 14 308 342 F 0
cm famotidine 6 HL60 HG-U133A 2 64 381 T 1
cm loperamide 6 HL60 HG-U133A 28 493 346 F 0
cm trichostatin A 6 HL60 HG-U133A 18 118 324 T 3
cm haloperidol 6 HL60 HG-U133A 36 61 262 T 3
cm perphenazine 6 HL60 HG-U133A 19 182 287 F 0
cm methotrexate 6 HL60 HG-U133A 2 42 266 T 1
cm paclitaxel 6 HL60 HG-U133A 9 1215 278 F 0
cm lisuride 6 HL60 HG-U133A 25 30 264 T 4
ae GSE10778 VEGF 1 HUVEC HG-U133A 7 268 272 F 0
ae GSE10778 EGF 1 HUVEC HG-U133A 11 356 311 F 0
ae GSE11367 IL-17 6 VSMC HG-U133 Plus 2 1 47 401 T 1
ae GSE14419 ZymosanA 3 macrophage HG-U133A 2 2 171 292 T 1
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ae GSE30242 mometasone
furoate
6 lung fibroblast HG-U133A 3 83 273 T 1
ae GSE35830 TGF-B3 10 Ect1 ectocervical ep-
ithelial cell
HG-U133 Plus 2 6 2 408 T 2
ae GSE27313 Wnt3a 6 MSC HG-U133 Plus 2 4 118 282 T 1
ae GSE16450 IFN-a 6 BE(2)-C HG-U133 Plus 2 2 97 243 T 1
ae GSE41683 dexamethasone 24 preadipocytes HuGene-1 0-st 4 785 339 F 0
ae GSE32217 EGF 48 keratinocyte HuGene-1 0-st 11 425 262 F 0
pp GSE6462 EGF 6 MCF7 HG-U133A 2 11 91 357 T 2
pp GSE6783 EGF 8 HeLa HG-U133A 11 142 325 T 2
pp GSE11710 TGF-B 6 HaCaT HG-U133 Plus 2 15 72 308 T 1
pp GSE18232 cobimetinib 48 HCT116 HG-U133A 2 1214 289 F 0
pp GSE11506 estradiol 3 MCF7 HG-U133 Plus 2 7 78 331 T 1
pp GSE6521 PD-168393 1 MCF7 HG-U133 Plus 2 3 130 334 T 1
cf GSE10315 BMP2 24 MSC HG-U133 Plus 2 19 10 396 T 5
cf GSE10315 BMP2 504 MSC HG-U133 Plus 2 19 374 306 F 0
cf GSE10315 TGF-B3 24 MSC HG-U133 Plus 2 6 38 402 T 1
cf GSE10315 TGF-B3 504 MSC HG-U133 Plus 2 6 21 345 T 1
cf GSE31283 valproic acid 48 HSC HG-U133A 12 5 227 T 2
cf GSE19393 dexamethasone 48 preadipocytes HG-U133 Plus 2 4 93 356 T 1
cf GSE19393 dexamethasone 48 preadipocytes HG-U133 Plus 2 4 255 362 F 0
cf GSE6460 FGF2 168 MSC HG-U133 Plus 2 12 25 322 T 2
cf GSE6460 TGF-B 168 MSC HG-U133 Plus 2 15 171 259 T 1
cf GSE32217 EGF 48 keratinocyte HuGene-1 0-st 11 1 252 T 2
cf GSE39157 cAMP - hepatoblast HuGene-1 0-st 10 143 272 T 1
cf GSE16910 activin A - hES-T3 HG-U133 Plus 2 10 86 422 T 1
cf GSE16910 activin A - hES-T3 HG-U133 Plus 2 10 15 354 T 3
cf GSE57032 R848 168 mMDSC OpArray Human
35K
2 2358 311 F 0
cf GSE57032 PAM3 168 mMDSC OpArray Human
35K
3 78 329 T 1
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cf GSE51398 inhibition of Atoh - ISC Mouse430A 2 9 529 370 F 0
cf GSE51398 dibenzazepine - ISC Mouse430A 2 10 56 359 T 1
cf GSE98147 CHIR99021 - dermomyotome HuGene-1 0-st 2 641 306 F 0
cf GSE69924 SB-431542 576 MEF Mouse430 2 4 1421 372 F 0
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Table 7.4: Signalling molecules predicted for the reversal of the cirrhotic state in rat liver. The molecules
obtaining rank up to 50 across correlation-based and length-based predictions are reported.
Signalling molecule Rank Gene symbols Receptor
NFYA 1 NFYA
ESR2 1 ESR2 yes
ADA3-like protein 1 TADA3
AHR 1 AHR yes
MMP-26 inh 1 MMP26
CHIP inh 1 STUB1
c-Jun/c-Fos inh 6 FOS;JUN
CBP inh 7 CREBBP
IFN-alpha inh 7 IFNA1;IFNA10;IFNA13;IFNA14;IFNA16;
IFNA17;IFNA2;IFNA21;IFNA4;
IFNA5;IFNA6;IFNA7;IFNA8
CIITA 8 CIITA
p90Rsk 8 RPS6KA1;RPS6KA2;RPS6KA3
NALP12 8 NLRP12
Somatotropin inh 9 GH1
MDM2 inh 10 MDM2
IRF1 inh 10 IRF1
Pitx2 inh 11 PITX2
SAP inh 11 SH2D1A
CD86 12 CD86 yes
CTLA-4 12 CTLA4
IL-2R beta chain inh 12 IL2RB yes
AP1G1 inh 12 AP1G1
AP-1 beta subunit inh 12 AP1B1
AP complex 2 medium (mu)
chain inh
12 AP2M1
AP1M1 inh 12 AP1M1
Beta-adaptin 2 inh 12 AP2B1
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IFN-beta inh 13 IFNB1
p53 14 TP53
Prolactin inh 15 PRL
SDF-1 inh 16 CXCL12
Endothelin-1 inh 17 EDN1
ECE2 inh 17 ECE2
p70 S6 kinase2 19 RPS6KB2
IRS-1 inh 19 IRS1 yes
MMP-2 inh 19 MMP2
TIMP1 20 TIMP1
ClO(’-) intracellular inh 21
TIRAP (Mal) inh 21 TIRAP yes
Androgen receptor 22 AR yes
ADAR1 22 ADAR
double-stranded RNA inh 22
GHR inh 23 GHR yes
TIE2 24 TEK yes
L-Carnitine cytoplasm 24
Glucocorticoids intracellular 24
Angiopoietin 3 inh 24 ANGPTL1
VEGF-A 26 VEGFA
MMP-19 26 MMP19
PTP-1B 26 PTPN1 yes
NPX1 26 NPTX1
Matrilysin (MMP-7) 26 MMP7
IGFBP7/8 inh 26 CTGF;IGFBP7
Pleiotrophin (OSF1) inh 26 PTN
Thrombopoietin inh 27 THPO
C/EBPbeta inh 30 CEBPB
IL-22RA2 31 IL22RA2 yes
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IL-22 inh 31 IL22
Angiopoietin 1 32 ANGPT1
Angiopoietin 4 32 ANGPT4
Angiopoietin 2 inh 32 ANGPT2
C1q 33 C1QA;C1QB;C1QC
Calreticulin inh 33 CALR
N-Acetyl-D-glucosamine intracel-
lular inh
33
MBL2 inh 33 MBL2
D-Mannose extracellular re-
gion inh
33
C4BP alpha inh 33 C4BPA
C1qRp inh 33 CD93 yes
PKC-beta 35 PRKCB
ACES 35 ACHE
COLQ 35 COLQ
Adenosine A2a receptor inh 38 ADORA2A yes
p120GAP 39 RASA1
GM-CSF receptor inh 40 CSF2RA;CSF2RB yes
c-MPL inh 40 MPL yes
FGF1 inh 40 FGF1
Heparin extracellular region inh 40
IL-3 receptor inh 40 CSF2RB;IL3RA yes
M-CSF receptor inh 43 CSF1R yes
IL-3 inh 43 IL3
IFN-kappa inh 44 IFNK
IFN-alpha/beta receptor inh 44 IFNAR1;IFNAR2 yes
IFN-omega inh 44 IFNW1
CSF1 inh 44 CSF1
ICAM3 45 ICAM3
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GATA-4 46 GATA4
IL-15 inh 47 IL15
IMP extracellular region inh 47
Detralfate extracellular region inh 47
JAB1 inh 48 COPS5
CISH 49 CISH
ULBP2 inh 49 ULBP2
RAET1G inh 49 RAET1G
ICOS-L inh 49 ICOSLG;LOC102723996
RAET1E inh 49 RAET1E
Prolactin receptor inh 50 PRLR yes
Lactogen inh 50 CSH2
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